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ABSTRACT
Retinal diseases involving degeneration of photoreceptors are an increasing cause of
blindness in this country, particularly among the aging population.  A solid understanding
of retinal development is central to combating photoreceptor degeneration on several
fronts.  Defining developmental processes may have therapeutic relevance in
‘rehabilitating’ photoreceptor cells that can be rescued from degenerative processes by
the application of exogenous trophic or survival factors.  Further, advances in stem cell
research may someday make replacement of photoreceptors a feasible therapy for the
treatment of retinal degeneration.  In this regard, it will be crucial that we have a clear
understanding of the developing retinal environment, and the combination of intrinsic
signals and extrinsic factors that influence retinal cells to adopt a photoreceptor cell fate.
The purpose of this study is to identify molecules important to rod genesis and
differentiation.  As a first step, we used 2 dimensional gel protein expression to identify
proteins that are dynamically expressed or modified during rod genesis.
Further we tested the role of mammalian target of rapamycin (mTOR) during
retinal development particularly during the ages of rod genesis and differentiation.
mTOR is involved in cell growth. We found that mTOR was expressed throughout retinal
development and although was found in rod photoreceptors did not appear to be specific
to them.  We also found that when retinal explants were exposed to rapamycin, an mTOR
inhibitor, for 10 days, rod differentiation decreased as assayed by rhodopsin expression.
This indicates a modulatory role of mTOR on rod photoreceptor differentiation
1.
CHAPTER 1: GENERAL INTRODUCTION
1.1 Introduction
Retinal diseases involving degeneration of photoreceptors are an increasing cause
of blindness in this country, particularly among the aging population.  A solid
understanding of retinal development is central to combating retinal disease.  Defining
developmental processes may have therapeutic relevance in ‘rehabilitating’ retinal cells
that can be rescued from degenerative processes by the application of exogenous trophic
or survival factors.
The goal of this dissertation is to begin to understand the factors involved in rod
photoreceptor differentiation.  We approached this goal using two different methods.  The
first was a holistic proteomics method to identify proteins present at developmental ages
important to rod photoreceptor genesis and differentiation.  We utilized ages E17, prior to
the peak of rod genesis, P0, the peak of rod genesis and P5, when rods have become
irreversibly fated to become rods.
The second approach was a more specific one, characterizing a particular protein,
mTOR, and its role in rod photoreceptor differentiation.  We characterized mTOR in
developing retinal tissues using immunohistochemistry and found that it is expressed
throughout retinal development.  It is found in photoreceptors but is not specific to them.
We also examined the two main binding partners of mTOR, raptor and rictor. They are
also expressed throughout retinal development.  To determine the functional role of
mTOR we applied the mTOR inhibitor, rapamycin to E17 retinal explant cultures.  The
2result was a decrease in rod photoreceptor differentiation suggesting a modulatory role of
mTOR in rod differentiation.
1.2 Dissertation Organization
This dissertation is organized into four chapters.  The first chapter is a general
introduction followed by a review of the literature.  The second chapter is a manuscript
characterizing the retinal proteome during rod photoreceptor genesis prepared for
submission to Investigative Ophthalmology and Visual Science.  Chapter three is a
manuscript characterizing the effect of the molecule, mTOR, on rod photoreceptor
differentiation prepared for submission to Vision Research.  Finally, chapter four is a
summary and discussion of the results with concluding remarks and comments for future
directions.
1.3 Literature Review
1.3.1 Structure and cell types of the retina
The retina has long been recognized as being a good structure to use in the study of
the central nervous system. This is largely due to its ease of accessibility and distinct
layered organization containing specific cell types (Ramón y Cajal 1892). The mature
retina is composed of discrete layers: 3 nuclear layers and 2 synaptic layers (Dowling
1987). These layers are the outer nuclear layer (ONL), the outer plexiform layer (OPL),
the inner nuclear layer (INL), the inner plexiform layer (IPL) and the ganglion cell layer
(GCL).
3There are 7 distinct cell types in the mature retina and they are all originally derived
from a common progenitor pool (Turner and Cepko 1987; Turner et al. 1990). Rod
photoreceptors are the low light sensing cell in the retina and have their cell bodies in the
outer nuclear layer. Rod photoreceptors comprise about 70% of the cells in the adult
mammalian retina and make up 97% of the photoreceptors (Jeon et al. 1998). Cone
photoreceptors are necessary for detecting color as they are sensitive to different
wavelengths of light and are also found in the outer nuclear layer. Photoreceptors
transduce light to neural impulses.  Bipolar cells transmit the neural impulse from the
photoreceptors to the ganglion cells either directly or indirectly via intermediate amacrine
cells. There are both rod and cone specific bipolar cells (Dowling 1987; Dowling and
Boycott 1966).  Bipolar cells are found in the inner nuclear layer. The outer plexiform
layer contains the synaptic connections between the photoreceptors and their respective
bipolar cells as well as the horizontal cells. Cone bipolar cells have a direct path whereas
rod bipolar cells transmit the neural impulse indirectly via AII amacrine cells. This is an
intermediate cell that communicates between the rod bipolar cell and the ganglion cell.
There are multiple types of amacrine cells, which are distinguished based on Golgi
staining and morphology.  They do not directly synapse with one another. Amacrine cells
and horizontal cells are found in the inner nuclear layer and mediate lateral interactions
(Dowling 1987). The inner plexiform layer has the synaptic connections between the
bipolar cells, amacrine cells and ganglion cells (Dowling 1987; Dowling and Boycott
1965). Bipolar cells and amacrine cells can give direct input to ganglion cells (Dowling
1987).  Ganglion cells in the ganglion cell layer convey the neural impulse through their
axons via the optic nerve.  Müller glia play a supportive role and span the retinal layers
4from the outer limiting membrane to the inner limiting membrane, of which is mostly
made up of the Müller glia end feet and astrocytes.
At early embryonic ages there is little to no lamination, or layering, in the retina (Pei
and Rhodin 1970). Structural layering occurs as the embryo develops. Retinal
development occurs in a central to peripheral manner. In the mouse, cell division, one
aspect of development, ceases centrally around postnatal day 5-6 but not until P11 in the
periphery of the retina (Young 1985a).  Central to peripheral maturation however, is not
limited to the mouse and exists in all other vertebrate species (Holt et al. 1988).
Complete retinal maturation occurs in the mouse at around six weeks of age where all
cell types and layers are present (Young 1985a).  Eye opening occurs around 2 weeks of
age.
1.3.2 Cell Fate Determination
Cells in the retina are born in a determined and conserved order (Young 1985a).
In most cases the cell types born at a given time overlap but there is a definite order
followed (Altshuler 1991; Cepko et al. 1996).  Retinal progenitor cells pass through a
characteristic set of “competency states” during which extrinsic cues can influence what
type of retinal neurons the progenitor cells will become (reviewed in Livesey and Cepko
2001a).  Each competency state is characterized by the limited subset of retinal neurons
that can be produced at that particular time during development.  For example, progenitor
cells from very early stages of retinal development give rise to ganglion cells or cone
photoreceptors, but are not intrinsically competent to give rise to rod photoreceptors
(Cepko et al. 1996). Thus, retinal development is a complicated process with different
5intrinsic and extrinsic factors thought to influence cell fate decisions of retinal progenitor
cells at different times during the process (Belliveau and Cepko 1999; Cepko et al. 1996;
Holt et al. 1988; Livesey and Cepko 2001a; Reh 1992; Turner et al. 1990).
1.3.3 Factors Influencing Retinal Cell Fate
Many factors have been found to affect cell fate determination, they can be
thought of as either intrinsic or extrinsic.  Intrinsic factors are inherent or endogenous to
the cell such as transcription factors.  Extrinsic factors are exogenous to the cell/system.
Potential factors can be stimulatory or inhibitory in regards to a particular cell type.
However, it is still unclear how these factors interact with each other and at what ages
each is most influential (Reviewed in Levine et al. 2000). One study found that co-
culturing rat embryonic retinal progenitors and postnatal retinal cells affected the cell
fates of the differentiating progenitors.  They concluded that there are two signals in the
postnatal retinal environment that affected the determination of retinal progenitor cell
fate.  One of these signals increased cone cell differentiation as evidenced by an increase
in cells positive for cone opsins and the other inhibited amacrine cell differentiation
(Belliveau and Cepko 1999).
1.3.4 Rod Photoreceptor Development
The majority of cells produced postnatally are rod photoreceptors and the most
definitive marker for differentiated rods is rhodopsin, the molecule that absorbs light and
initiates phototransduction (Cepko et al. 1996; Young 1985a). The earliest marker for
rods is neural retina leucine zipper (Nrl) (Farjo et al. 1993; Swain et al. 2001; Swaroop et
6al. 1992).  Nrl is a leucine zipper transcription factor (Swain et al. 2001; Swaroop et al.
1992).  In the retina it is exclusively expressed in rods and is needed for rod
photoreceptor development (Farjo et al. 1993; Mears et al. 2001; Swain et al. 2001;
Swaroop et al. 1992). In the Nrl knockout mouse, there is a complete loss of rod
differentiation, no detectable rod function and all the photoreceptors have cone like
characteristics (Mears et al. 2001).  Nrl induces rod promoter activity alone and in
combination with cone rod homeobox protein (Crx) (Mitton et al. 2000). In the mouse,
rods are at their peak of genesis at birth, P0. They begin to express rhodopsin at P3 to P5
although the time from cell genesis to rhodopsin expression varies.  As noted previously,
the birth order of retinal cell types (“birth” being the time at which retinal progenitor cells
undergo their terminal mitotic division) is well established.  However, what is still not
known is when and how they make an irreversible cell fate decision. For rods, in the
developing rat retina, it seems to be in the first postnatal week coinciding with the time
that they start expressing rhodopsin based on studies that were able to alter cell fate
determination (Ezzeddine et al. 1997).  In one particular study, addition of CNTF to rat
retinal explants caused a decrease in the number of differentiated rods but once the rod
photoreceptors expressed rhodopsin their fate determination could not be altered by the
addition of CNTF (Ezzeddine et al. 1997).  It is important to better understand how
intrinsic mechanisms and extrinsic factors drive a cell to its fate. This motivates our
efforts to identify proteins that peak during rod photoreceptor genesis and/or
differentiation based on the hypothesis that proteins important for rod differentiation will
be dynamically expressed after genesis of presumed rod photoreceptors.
71.3.5 Extrinsic Factors
Many extrinsic factors have been investigated for their effect on retinal
development.  These include fibroblast growth factors, Sonic hedgehog, retinoic acid,
taurine, 3-isobutyl-1-methylxanthine, brain derived neurotrophic factor, leukemia
inhibitory factor and ciliary neurotrophic factor. Basic fibroblast growth factor (bFGF or
FGF2) is a member of the fibroblast growth factors. When bFGF is included in cell
culture media it is thought to keep cells in an undifferentiated state.  FGF1 and FGF2
were some of the first identified factors shown to affect rod photoreceptor differentiation.
These factors stimulated rhodopsin expression in rat retinal cells cultured in vitro and
increased the number of cells positive for rhodopsin (Hicks and Courtois 1988; Hicks and
Courtois 1992).  Additionally, FGF was found to cause a proliferation in both rat
monolayer cell cultures and retinal explants with progenitor cells from younger ages
being more responsive to FGF (Lillien and Cepko 1992).
Similarly, Sonic hedgehog (Shh) was found to have a positive effect on rod
differentiation. When added to rat retinal cell cultures Shh resulted in an increase in the
number of differentiated rods (Levine et al. 1997).  A recently published study showed a
similar effect when Shh was added to purified mouse embryonic stem cells positive for
retinal homeobox gene and cultured in retinal culture medium (Osakada et al. 2008).
This condition promoted rod photoreceptor differentiation but an even greater effect was
seen with the combination of acidic fibroblast growth factor, basic fibroblast growth
factor, Shh and retinoic acid (Osakada et al. 2008).  Retinoic acid (RA) is another
extrinsic factor that positively affects rod photoreceptor development.  Like Shh, when
RA was added to dissociated rat retinal cells, the number of differentiated rods increased
8(Kelley et al. 1994). Recently, another group demonstrated that RA affects rod
development by regulating Nrl (Khanna et al. 2006). They found that Nrl protein
increased in cultured rat and porcine photoreceptors as well as in Y79 cells, a human
retinoblastoma cell (Khanna et al. 2006).  In a separate study, RA added to prenatal and
perinatal rat retinal cell cultures, did not have an effect on rod numbers but it did speed
up the rate of rhodopsin expression in explants and cultures of rat embryonic retinas
(Wallace and Jensen 1999). Two other extrinsic factors tested in this same study were
found to accelerate rhodopsin expression were taurine and 3-isobutyl-1-methylxanthine
(IBMX) (Wallace and Jensen 1999).  All three of these factors were postulated to have an
effect on rhodopsin negative cells speeding their differentiation into rhodopsin positive
cells but not increase the total number of cells to express rhodopsin (Wallace and Jensen
1999).  RA had the greatest effect followed by IBMX with the least potent effect by
taurine (Wallace and Jensen 1999).  Taurine has also been shown to be expressed in
rodent retina during embryonic development (Altshuler et al. 1993).  Taurine, when
added to rat retinal cultures had a stimulatory effect on rod photoreceptors (Altshuler et
al. 1993).  A gene was found that was upregulated by the addition of taurine called
Taurine Upregulated Gene 1 (Young et al. 2005).  When this gene was knocked down,
there was a malformation of photoreceptor outer segments (Young et al. 2005).
Another extrinsic factor that has been shown to affect rod development is brain-
derived neurotrophic factor (BDNF).  It has an indirect effect on rod photoreceptors.
BDNF acts through the TrkB receptor. This receptor is found in Müller glia, retinal
pigmented epithelial cells, ganglion cells and amacrine cells but not rod photoreceptors
(Rohrer et al. 1999).  In TrkB knock out mice, rod photoreceptors developed but were
9delayed compared to the wild types (Rohrer et al. 1999). The postnatal day 16 mutants
were comparable to the postnatal day 12 wild type mice in rhodopsin content,
electroretinogram (ERG) analysis and outer segment dimensions (Rohrer et al. 1999).
Photoreceptors cannot directly respond to BDNF, but these observations suggest that
their development is dependent on interactions with cells that do. The cells that are
activated by BDNF are Müller glia, ganglion cells and amacrine cells, though retinal
pigmented epithelial cells could not be ruled out (Rohrer et al. 1999).
Other extrinsic factors that have been described include those that inhibit the
development of rod photoreceptors. Two such factors are Müller-cell-derived leukemia
inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF). These factors were first
discovered when it was noticed that in dissociated cell cultures of rat retina, rods would
not differentiate, based on morphology and expression of rhodopsin (Sparrow et al. 1990;
Watanabe and Raff 1990).  Based on this observation, a study was performed in rat and
mouse dissociated retinal cell cultures to determine what was causing this effect
(Neophytou et al. 1997).  It was found that rods would not develop in the presence of
fetal calf serum (FCS) but they would develop in culture if the serum was absent and the
cell density was high enough (Neophytou et al. 1997). Neophytou et al. reported that FCS
had a positive effect on Müller glia cell numbers in culture and that the inhibitory effect
of FCS on rod photoreceptors was likely due to the excretion of LIF from the increased
number of Müller glia cells (Neophytou et al. 1997).
The second extrinsic factor to have a known negative effect on rod photoreceptor
development is ciliary neurotrophic factor (CNTF).  Addition of CNTF to postnatal rat
retinal explants was found to decrease the number of differentiated rods (Ezzeddine et al.
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1997). In this study the cells that were immunoreactive for bipolar cell markers were
increased. It was presumed that the cells fated to be rod photoreceptor cells were re-
specified with the addition of CNTF to become bipolar cells if it was early enough
(Ezzeddine et al. 1997).  However, once cells began to express rhodopsin, they could no
longer be affected by CNTF.  Another group using the same paradigm did not see the
increase in other cell types but did observe an inhibition of rod photoreceptors in rat cell
culture (Kirsch et al. 1998). In another study using early postnatal rat retinal slices, the
effects of CNTF in rat on rod photoreceptors were not permanent (Schulz-Key et al.
2002). They found that rods decreased but only transiently. The rods returned to normal
numbers and the ONL was intact after a delay of 3-4 days.
1.3.6 Intrinsic Factors
There are also many known intrinsic factors that affect rod photoreceptor
development.  Some of these include neural retina leucine zipper (Nrl), Crx, Otx2, Cyclin
D1, retinoblastoma protein (Rb), Nr2E3 and NeuroD.
The factor first expressed specifically in rods is neural retina leucine zipper (Nrl).
Mears et al. found that it acts with Crx to regulate rhodopsin transcription (Mears et al.
2001). In Nrl knockout mice, rod photoreceptors do not form and cone like cells that have
connections with rod bipolar cells take their place (Strettoi et al. 2004).
Crx is an Otx-like homeodomain transcription factor and is expressed prenatally
during retinal development (Hennig et al. 2007; Rutherford et al. 2004).  Chx10 is a gene
expressed in neural progenitor cells and when mutated causes microphthalmia in humans.
Chx10 mutant mice do not form normal rod or cone outer segments.  Crx was not
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expressed in these mice during embryonic retinal development but was detected
postnatally (Rutherford et al. 2004).  Crx is part of a larger network of genes involving
photoreceptor fate determination and development (Hennig et al. 2007).
Otx2 is another gene that is part of this photoreceptor network and it functions to
regulate Crx (Hennig et al. 2007).  Otx2 is expressed in the developing nervous system
including the retina and retinal pigmented epithelium (RPE) (Hennig et al. 2007).  Cyclin
D1 is a key regulator of the cell cycle and over expressed in many cancers.  Mice that are
deficient in Cyclin D1 not only have microphthalmia and thin retinas but their
photoreceptors have an increased death rate (Ma et al. 1998).
Another known intrinsic molecule that affects rod photoreceptor development is
retinoblastoma protein (Rb). Retinoblastoma protein is responsible for both proliferation
and differentiation in the central nervous system (Ferguson and Slack 2001; Slack et al.
1998).  Knockout Rb mice do not survive after birth (Zhang et al. 2004b).  In mice in
which Rb has been inactivated by a replication-incompetent retrovirus in single retinal
progenitor, knock out cells will proliferate but no rods will differentiate to maturity
(Zhang et al. 2004b).  Zhang et al. hypothesized that Rb’s role in cell fate determination
is due to binding to the E2F transcription factor regulating cell cycle exit using this
pathway (Zhang et al. 2004b).
Nr2e3 is a nuclear receptor that is specific to photoreceptors (Chen et al. 2005).
Nr2e3 is necessary for normal rod cell fate specification and development while it also
suppresses cone cell proliferation (Haider et al. 2006).  In retinal degeneration (rd7) mice,
lack of Nr2e3 causes a proliferation in cone photoreceptors as well as retinal dysplasia
(Haider et al. 2001).  In humans, an analogous condition called enhanced S-cone
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syndrome is also characterized by a retinal degeneration and an increase in cones.  It was
reported that Nr2e3 was expressed only in vertebrate rod photoreceptors but, Haider et al.
found that in mice, Nr2e3 is expressed in late retinal progenitor cells as well as
differentiating photoreceptors (Chen et al. 2005; Haider et al. 2006). Nr2e3 was also
found in mouse mature rod and cone cell bodies (Haider et al. 2006).
NeuroD is a basic helix loop helix (bHLH) transcription factor that is found throughout
the central nervous system and retina (Pennesi et al. 2003).  It is involved in cell fate
determination and differentiation (Cepko 1999; Pennesi et al. 2003).  NeuroD is
expressed in several cell types of the retina including amacrine cells, developing
photoreceptors and in the adult mature photoreceptors, potentially having differing roles
dependent on cell type (Inoue et al. 2002; Morrow et al. 1999).  It likely works with other
transcription factors such as Math3, to bring about changes in non-photoreceptor cell
types (Inoue et al. 2002).  Alone its effect is mainly in photoreceptor fate determination
in the developing retina (Cepko 1999; Inoue et al. 2002; Pennesi et al. 2003). One study
reported an increase in Müller glia in NeuroD knockout explants (Morrow et al. 1999).
Another group did not see similar changes in amacrine cell fate or Müller glia
differentiation unless both Math3 and NeuroD were knocked out (Inoue et al. 2002).
NeuroD knockout mice displayed reductions in both rod and cone driven ERG’s in
prenatal, postnatal and adult age groups (Pennesi et al. 2003).  These NeuroD null mice
also showed evidence of photoreceptor degeneration and coupled with its presence in
mature photoreceptors suggests a role in photoreceptor maintenance as well (Pennesi et
al. 2003).
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1.3.7 Mammalian Target of Rapamycin (mTOR)
The Target of Rapamycin (TOR) proteins, specifically TOR1-1 and TOR2-1,
were first isolated in yeast with a specific point mutation in the FRB domain of the
protein that was not affected by the growth inhibitor rapamycin (Heitman et al. 1991;
Schmelzle and Hall 2000). This mutation did not allow the normal binding of the FKBP-
rapamycin complex. The signaling pathways are distinctively different between the
TOR’s in yeast and the mammalian TOR (mTOR).  There are 2 TOR proteins in yeast
and they both perform the same function in regards to increasing cell growth in response
to nutrient availability (Abraham 2002; Thomas and Hall 1997). TOR2 has an additional
function in controlling the actin cytoskeleton that is not sensitive to rapamycin (Abraham
2002; Thomas and Hall 1997).  Both proteins also signal initiation of translation via
phosphatases and TAP42 (Abraham 2002).
There is a TOR in Drosophila known as dTOR (Bateman and McNeill 2004).  In
the Drosophila eye, the dTOR pathway was reported to be responsible for activation of
neuronal differentiation.  dTOR has a conserved structure and has 56% of its amino acids
in common with the mammalian homolog (Oldham and Hafen 2003; Oldham et al. 2000;
Zhang et al. 2000).  Drosophila spp. have been used to mine the function of the TOR
pathway in metazoans (Bateman and McNeill 2004).  Mammalian Target of Rapamycin
(mTOR) is a 235 kDa Phosphatidylinositol kinase (PIK)-related kinase with multiple
functions in cell growth (Schmelzle and Hall 2000). Mammalian TOR has been identified
in rat, mouse and human.  mTOR is regarded as a central regulator of cell growth as
cyclin dependant kinase is a central regulator of cell proliferation (Schmelzle and Hall
2000). Downregulation of mTOR allows differentiation as shown in certain cell lines,
14
vascular smooth muscle and the CNS (Martin et al. 2007; Que et al. 2007; Swiech et al.
2008).
1.3.8 mTOR Pathway and Signaling
Cell growth is an increase in cell size in contrast to cellular proliferation which
increases cell numbers.  The mechanisms behind cell growth have not been as widely
studied as those of cellular proliferation.  One major way that mTOR affects cell growth
is through initiation of translation.  It does this in two main pathways via either p70s6k or
4EBP1.  First, in the presence of amino acids and growth factors, mTOR activates p70s6k
which then phosphorylates S6, a 40s ribosomal protein that drives the translation of 5’
terminal oligopyrimidine tract (TOP) mRNA’s (Meyuhas 2000; Oldham and Hafen
2003).  mRNA’s that contain the 5’ TOP, called TOP mRNA’s, encode components
needed for translation (Meyuhas 2000). Second (also in the presence of amino acids and
growth factors) mTOR inhibits 4EBP1, a translation inhibitor that exerts its effect on
elF4E.  elF4E is also important is translating mRNA’s with 5’ untranslated regions.
There are two main binding partners for mTOR both with differing roles.  mTOR
will bind either raptor (regulatory associated protein of mTOR) or rictor (rapamycin-
insensitive companion of mTOR). When bound, these complexes are called mTORC1
and mTORC2.  Binding with raptor is necessary for phosphorylation of 4EBP1.  Binding
of p70 alpha seems to be needed for the phosphorylation of 4EBP1. The raptor pathway is
responsible for regulation of cell growth, an increase in the mass of each cell. If mTOR
binds to rictor it activates Akt or protein kinase C (PKC) alpha and the actin cytoskeleton.
Akt along with protein kinase B (PKB) is downregulated in many cancers and activation
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causes more aggressive tumors so PKB/Akt is thought to be an important part of the
pathophysiology of neoplasia (Sarbassov et al. 2005b).  The rictor pathway is responsible
for regulation of cell proliferation, an increase in the number of cells, metabolism and
cytoskeleton (Sarbassov et al. 2005a).  This pathway has been considered rapamycin
insensitive but a recent study showed that this may not be the case (Sarbassov et al.
2006).   When rapamycin is applied for a long period of time eventually all of the free
mTOR is bound leaving none for rictor to bind with (Sarbassov et al. 2006).
The mTOR signaling pathway can be activated by the binding of insulin like
growth factor (IGF) to the IGF-1 receptor. IGF-1 receptors are tyrosine kinases (White
2003; Yi et al. 2005).  In order to exert a downstream effect they must attract and
phosphorylate other proteins (White 2003).  Insulin receptor substrate (IRS) proteins are
activated by the IGF-1 receptor. When IGF-1 binds to its receptor, IGF-1 receptor
dimerizes and autophosphorylation of the receptor occurs.  This causes a phosphorylation
of the insulin receptor substrate (IRS) protein downstream. In retina it is insulin receptor
substrate-2 (IRS-2) and this protein has been implicated in photoreceptor survival and
maturation (Yi et al. 2005).  In this study, Irs2 knockout mice had a reduction of 50% of
their photoreceptors by postnatal week two and a total loss by 16 months (Yi et al. 2005).
IRS binds the p85 PI3K adaptor which then binds the p110 PI3k catalytic subunit
(Oldham and Hafen 2003).  This binding at the plasma membrane converts
phosphatidylinositol (4,5)-bisphosphate (PIP2) to PIP3 (Oldham and Hafen 2003).  A
negative regulator of PIP3 is PTEN, when PTEN function is lost then overgrowth occurs
in Drosophila (Oldham and Hafen 2003).  Protein kinase B, also known as Akt, is a
16
potential regulator of the PIP3/PTEN complex (Oldham and Hafen 2003).  It is Akt that
activates mTOR.
1.3.9 Proteomics
Proteomics is a broad experimental approach that is a useful tool in the study of
retinal development.  Proteomics, particularly 2 dimensional gel electrophoresis has been
used successfully for over 30 years (O'Farrell 1975).  As genomics is mapping all of the
genes in a certain organism, proteomics is the study of all the proteins present in a cell at
a particular time.  Proteomics gives a snapshot of the genes that are expressed at certain
times or under certain conditions.  Proteomics is more context dependent because, one
gene, considering post-translational modifications can encode up to 50 different proteins
(Cho 2007b).  Having the genome helps understand the possible protein combinations but
only proteomics gives a true picture of what proteins are actually translated at any given
time.
Proteomics includes many different techniques such as two dimensional
polyacrylamide gel electrophoresis (2-D PAGE), liquid chromatography (LC) and
isotope-coded affinity tag (ICAT) (Cho 2007b).  The first set of techniques separates the
proteins while mass spectrometry is needed for identification of proteins. 2-D PAGE
allows separation of protein on gels based on 2 criteria, molecular weight and isoelectric
focusing point (the pH at which the net charge is zero).  Because it is separated according
to two different criteria, the majority of spots on the gel represent one protein.  Liquid
chromatography (LC) is one way to separate and quantify the proteins in a sample (Cho
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2007b).  LC can be combined with mass spectrometry for best results in a complex
mixture.
Protein spots of interest are picked and trypsin digested in preparation for
identification by Mass spectrometry.  Mass spectrometry is the technique used to identify
proteins separated by one of the previously mentioned methods. It calculates the
molecular masses of protein fragments based on the mass to charge ratio (Cho 2007b).
There are different methods to prepare the proteins for mass spectrometry but two most
widely used approaches are electrospray ionization (ESI) and matrix-assisted laser
desorption/ionization (MALDI) (Cho 2007b).  As it’s name suggests, electrospray results
in a spray of small droplets which are then made into even smaller droplets (Cho 2007b).
The resulting ions are then passed to the mass spectrometer, usually with a quadropole.
MALDI dissolves the samples in a crystalline structure that absorbs UV light, the matrix.
A laser excites the sample dissolved in the matrix causing the ions to be released in a gas
form (Cho 2007b).  The excited ions are passed through a flight tube and the molecular
weights are established based on their time of flight (TOF).  This concept is based on
masses relation to its velocity at a constant voltage (Cho 2007b).  The mass spectrometer
gives a reading of the peptide fragments masses and the information is fed into a
computer. The computer can be used to search available online searchable protein
databases such as MASCOT to find the best match for protein identification.  MASCOT
searches the SwissProt and Trembl web databases.  Variables for protein modifications
can be set according to the users criteria.
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ICAT is useful when the protein structure and function is of interest.  ICAT
allows labeling of specific proteins and can be used in combination with 2-D PAGE (Cho
2007b).  ICAT allows the user to put two samples of interest together and run on one gel.
While only one of several techniques, reproducible separation of proteins in two-
dimensions has opened the door for widespread profiling of protein expression. Recent
advances in 2-dimensional gel electrophoresis technology and computer based analysis
have made this an effective way to separate the hundreds of proteins present in a sample
and is already being used to generate proteome maps as well as ask specific experimental
questions.  Some of these studies have used yeast (Ideker et al. 2001; Pandey and Mann
2000; Sarry et al. 2007; Vido et al. 2001), plants (Kersten et al. 2002; Lee et al. 2007b;
Ryan et al. 2001), immune-cells (Le Naour et al. 2001a; Lee et al. 2007a), bovine eye
(Nishizawa et al. 1999), cancerous cells (Celis et al. 2002; Gagne et al. 2007; Li et al.
2005a; Luo et al. 2005; Pucci-Minafra et al. 2002; Wu et al. 2002), synaptosomes
(Jimenez et al. 2002), plant development (Kersten et al. 2002; Lonosky et al. 2004; Ryan
et al. 2001), post-golgi compartment (Morel et al. 2000), pulmonary fibrotic tissue
(Malmstrom et al. 2002) and brain tissue (Skold et al. 2002; Xu et al. 2007).  There are
many unanswered questions regarding cancer.  Many studies are using 2-D gel separation
to identify differences between neoplastic and normal tissues and cells in order to identify
possible treatment strategies, therapeutic targets and biomarkers (Cho 2007a).  For
example, some comparative studies of normal tissue versus neoplastic tissue are breast
cancer (Luo et al. 2005) and ovarian cancer (Gagne et al. 2007).  A study on hepatic
cancer due to hepatitis B virus used proteomics to identify potential markers for the
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disease (Li et al. 2005a).  There is also a study examining the proteomics of
atherosclerotic plaque formation in humans (Donners et al. 2005).
Recent advances in genomics have greatly furthered the information and genomic
data available today.  Proteomics is a great adjunct in helping the understanding of gene
function by aiding in sorting through the vast amounts of information (Cho 2007b;
Miklos and Maleszka 2001; Pandey and Mann 2000 ; Pawson and Nash 2003).
Proteomics will show which of those proteins are actually present, and how they may be
modified at various stages of development and what changes are present in disease states.
Proteomics combined with genomics is becoming a powerful tool to investigate
biological function.
Retinal development remains an active and well studied area, yet proteomics still
remains an underutilized technology in this field. One early retinal related study
examined the drusen protein which is found in people with age-related macular
degeneration using proteomic techniques (Crabb et al. 2002).  Two recent studies have
used proteomics to study the developing retina.  In one study, 2-D gel electrophoresis
coupled with MALDI-MS and peptide mass fingerprinting was used to create a protein
database for developing chick retinas (Lam et al. 2006).  In another, the proteome of the
postnatal mouse retina was studied using 2-D gel electrophoresis with MALDI-MS and
peptide mass fingerprinting (Haniu et al. 2006). In this study they grouped proteins
according to when they are expressed. There were four groups of proteins, those that are
expressed in the juvenile state, those that are expressed in the adult state, those that are
expressed transiently between juvenile and adult and those that are expressed regardless
of postnatal age (Haniu et al. 2006). There is currently no comprehensive data available
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on the proteomic catalog of developing retina.  Categorizing what proteins are expressed
at each age will be helpful in understanding development and how it changes over time.
A proteomics approach to rod photoreceptor development will allow us to identify the
most likely proteins involved, form new testable hypotheses and better focus future
studies.
1.3.10 Clustering
Clustering is a common technique used to manage large datasets. Clustering in
general can be defined as a way to group subsets of data points into groups with like data
points (Jain et al. 1999; Kohonen 2001).  It is also known as data segmentation.  Most
commonly, data points are clustered by determining the distance to the nearest cluster.  In
other words, the data points that are closest together in space are grouped together (Jain et
al. 1999).
To understand the higher levels of learning algorithms it is necessary to start with
the basics of simpler algorithm theories.  There are two main groups, hierarchical and
non-hierarchical both subdivided into many other categories.  There are many other ways
to classify the different types of algorithms but for the purposes of this dissertation I will
stay with hierarchical versus non-hierarchical.  A potential drawback to clustering is that
it will always produce clusters, even if the data points are evenly distributed (Jain et al.
1999; Kohonen 2001).
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1.3.10.1 Hierarchical Clustering
There are two basic types of hierarchical clustering:  divisive, which tends to split
clusters and agglomerative, which tends to merge clusters (Jain et al. 1999) (Kohonen
2001).  A diagram called a dendogram is used to represent hierarchical clustering and
resembles a tree diagram with branch lengths corresponding to the strength of the
relationship (Jain et al. 1999; Kohonen 2001; Tamayo et al. 1999).  Hierarchical
clustering is accomplished through a series of successive steps grouping like data points
(agglomerative).  Differences happen depending on the definitions used for distance.
1.3.10.2 Non-hierarchical Clustering
There are many more types of non-hierarchical clustering.  Some are simple such as
simple K- (exclusive clustering algorithm) and Fuzzy K-means (overlapping clustering
algorithm) and others are more elegant such as Self Organizing Maps (SOM).  As
mentioned previously, clustering uses distance as a means to group like data points.  One
way this is accomplished is using Euclidian distance, the measure of the straight line
between two points (Kohonen 2001). This is not always the ideal method of measurement
especially when scaling is taken into consideration.  In cases of higher dimensional data
like ours, another measure called the Minkowski Metric can be used where distance is
measured based on a generalization of Euclidian distance (Kohonen 2001).
1.3.10.3 K-means clustering
K-means clustering is one of the simplest learning algorithms. This unsupervised
learning algorithm defines K numbers of centroids, one for each cluster (Kohonen 2001).
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The centroids are scattered away from one another and data points are assigned to the
closest centroid. Once this is done, the centroids are recalculated and data points
reassigned or assigned if it is called for.  This process is repeated until the centroids no
longer move.  Because it is a simple algorithm it may not always group the data into the
best clusters (Tamayo et al. 1999).  The results are dependent on the number and
placement of the initial centroids.
1.3.10.4 Fuzzy K-means
Utilization of Fuzzy K-means addresses some of the problems associated with K-
means. As the name suggests, centroid boundaries are not clear.  It is similar to K-means
but the data points can have different degrees of membership to one or more centroids as
opposed to K-means where a point can have only one degree of membership to only one
centroid (Bezdek 1981; Jain et al. 1999).  The steps are then similar but there is higher
likelihood of a data point being assigned to the appropriate cluster (Bezdek 1981).
1.3.10.5 Adaptive Resonance Theory and Self Organizing Maps
The two types of algorithms used for my data were Adaptive Resonance Theory 2
(ART2) and Self Organizing Maps (SOM).  Both of these algorithms are considered
artificial neural network algorithms because they were modeled after human neural
networks and the activities they are responsible for such as learning and memory
(Aleshunas et al. 1994; Kohonen 2001). ART2 and SOM are both also categorized as
unsupervised learning algorithms. They are called unsupervised because supervised
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learning algorithms require prior knowledge or experience in the network. Since there is
no expected outcome (i.e. it is unknown) these algorithms are unsupervised.
ART2 is a way to determine the appropriate number of clusters.  It does this
through a process of adaptation.  After determining the number of clusters needed for a
data set this number can then be used to run the data through SOM (Tamayo et al. 1999).
A major advantage of ART2 is that it can learn new information without losing the old
information unlike most previous algorithms (Aleshunas et al. 1994).  This is known as
the stability-plasticity dilemma a term coined by one of the developers of this algorithm.
This just means that stability is the preservation of previous cluster and plasticity is the
ability to add a new cluster (Aleshunas et al. 1994). ART2 does this by creating a new
cluster when a data point does not fit with the previous ones.  A main problem with
ART2 is the potential to become proliferative, that is, continuing to add new clusters
without stopping, also known as overfitting.
SOM takes data that is in high dimensional space and attempts to put it into lower
dimensional space while preserving the topography. It uses competition, cooperation and
adaptation (Aleshunas et al. 1994; Kohonen 2001).  Competition means that given certain
inputs some clusters become activated.  Those that are activated the most “win”.
Cooperation means that the winner spreads this activation to create the network.  Finally,
adaptation means that the winner and the network with its neighbors adapt themselves in
order to best suit the inputs.
SOM is competitive like human neural networks. Nodes are determined by use or
disuse and by a series of interactions including lateral interactions and inputs (Aleshunas
et al. 1994; Kohonen 2001; Tamayo et al. 1999).  Those training networks that are not
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being used decrease over time.  The result is a trained network where nodes that are close
are similar and those that are farther away are different. One limitation to SOM is that it
should not be used for pattern recognition (Aleshunas et al. 1994; Kohonen 2001). It
takes data points through a series of iterations and ends up putting them in a lower
dimensional grid while always retaining the topology (Tamayo et al. 1999).
1.3.11 Summary
The environment during retinal development and differentiation is of utmost
importance.  Understanding this environment and its interactions will be key to
uncovering the mechanism of cellular differentiation in the retina.  This information will
allow for a better understanding of the developmental process and also will begin to
address controlling cell fate decisions made by retinal stem cells transplanted to treat
retinal degeneration.  Proteomics is a powerful tool to accomplish this goal.
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CHAPTER 2: CHARACTERIZATION OF THE RETINAL PROTEOME
DURING ROD PHOTORECEPTOR GENESIS.
A paper to be submitted to Investigative Ophthalmology and Visual Science
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2.1 Abstract
Purpose:  The process of rod photoreceptor genesis, cell fate determination and
differentiation is complex and multi-factorial.  Previous studies have defined a model of
photoreceptor differentiation that relies on intrinsic changes within the presumptive
photoreceptor cells as well as changes in surrounding tissue that are extrinsic to the cell.
We have used a proteomics approach to identify proteins that are dynamically expressed
in the mouse retina during rod genesis and differentiation.
Methods:  A series of six developmental ages from E13 to P5 were used to define
changes in retinal protein expression during rod photoreceptor genesis and early
differentiation.  Retinal proteins were separated by isoelectric focus point and molecular
weight.  Gels were analyzed for changes in protein spot intensity across developmental
time. Protein spots that peaked in expression at E17, P0 and P5 were picked from gels for
identification.
Results: There were 239 spots that were picked for identification based on their dynamic
expression during the developmental period of maximal rod photoreceptor genesis and
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differentiation.  Of the 239 spots, 170 of them returned reliable identities.  Twenty-three
proteins were represented by multiple spots, suggesting they were post-translationally
modified.  Of the 107 distinct proteins identified, only 11 had been previously reported to
be associated with the developing retina.
Conclusions:  Our results represent the first proteomics study of the developing mouse
retina that includes prenatal development.  We identified 23 proteins with dynamic post-
translational modifications and 96 proteins with dynamic expression in the developing
retina whose dynamic expression had not yet been reported in the developing retina.
2.2 Introduction
Retinal diseases involving degeneration of photoreceptors are an increasing cause
of blindness in this country, particularly among the aging population. Advances in stem
cell research may someday make replacement of photoreceptors a feasible therapy for the
treatment of retinal degeneration.  MacLearen and colleagues 1recently reported that only
post-mitotic rod precursors were able to successfully and functionally integrate into the
mature retina.  Currently we are not able to reliably bias stem cells to adopt a
photoreceptor fate.  In this regard, it will be crucial that we have a clear understanding of
the retinal environment during normal photoreceptor genesis as well as the combination
of factors both intrinsic and extrinsic to developing retinal cells that influence their
decision to adopt a photoreceptor cell fate.  To this end we have characterized the
developmental proteome of the mouse retina during late embryonic and early postnatal
development, the time when the vast majority of rod photoreceptors are born, commit to
their cell fate and begin to differentiate.  Retinal progenitor cells pass through a
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characteristic set of competency states during which extrinsic cues can influence what
type of retinal neurons they will become 2. Progenitors in the developing retinal
environment during later development are strongly biased towards rod photoreceptor
differentiation.  Thus, if we are to learn how to bias stem cells to adopt at first a retinal
and then a photoreceptor cell fate, characterizing protein expression during later stages of
retinal neurogenesis seems a reasonable starting point.
We have used two-dimensional gel electrophoresis to profile protein expression in
developing mouse retinas during late stages of retinal neurogenesis.  Self-organizing
mapping (SOM) was used to cluster protein spots into groups based on their changing
levels of expression across developmental time.  From this we identified clusters of
proteins that peaked in expression at embryonic day 17 (E17; prior to the peak of rod
genesis); birth (P0; during the peak of rod genesis) and postnatal day 5 (P5; a time when
rods are making irreversible cell fate commitment decisions and have begun to
differentiate).
In this analysis we separated 474 distinct protein spots. Of those spots, 60 peaked
in expression at E17, 56 peaked at P0 and 123 peaked at P5 and were picked for
identification.  One hundred and seventy protein spots (71.1%), representing 107 distinct
proteins returned identities that could be confirmed based on molecular weight by manual
inspection of the gel images.  An analysis of the literature revealed that 11 of the
dynamically expressed proteins had a previously published link to retinal development.
Further, 23 of the identified proteins were represented by multiple spots, indicating
dynamic changes in their migration characteristics during retinal development, likely due
to post-translational modification.  This analysis has identified proteins that are
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dynamically expressed or modified in the retina during rod genesis and differentiation,
and has therefore generated a list of candidate proteins for further investigation.
2.3 Materials and Methods
Sample Preparation: Pups were taken from timed pregnant C57BL/6 mice at
ages E13, E15, E17, E18, day of birth (P0) and P5.  Eyes were enucleated and retinas
immediately placed in ice cold Phosphate Buffered Saline (PBS, 0.14M NaCl, 2.68mM
KCl, 10.14mM Na2HPO4,  1.76mM KH2PO4, pH 7.2). The tissue was suspended in
rehydration buffer (8M Urea, 2% CHAPS, 0.5% ZOOM Carrier Ampholytes (Invitrogen,
Carlsbad, CA), 0.002% bromophenol blue and 20mM DTT), sonicated for 30 seconds
and spun at 4,000 rpm for 10 minutes at 4oC.  The pellet was re-suspended in rehydration
buffer (RHB).  The sample was spun again at 4,000 rpm for 10 minutes at 4oC.  The
remaining supernatant was collected and frozen at -80oC.  The total protein concentration
was determined using the EZQ protein assay (Invitrogen).  The sample was diluted to a
final concentration of 35µg per 165µl (0.212 µg/µl).  All experiments were conducted in
accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research.
Two-dimensional separation of protein spots:  Proteins were separated on the
basis of their isoelectric focus poing (pI) using a ZOOM IPGRunner 7cm strip pH 3-10
(Invitrogen). The total protein loaded on the strip was 35µg.  The first dimension running
conditions were as follows: 20 minutes at 200V, 15 minutes at 450V, 15 minutes at 750V
and 45 minutes at 2000V.  Proteins were separated by molecular weight using a 7cm Bis
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Tris 3-12% pre-cast gel (Invitrogen).  The gels were subjected to a continuous voltage of
200V for 50 minutes.
The gels were fixed with 50% Methanol, 10% Trichloroacetic acid overnight,
washed in ddH20 followed by a wash in 10% methanol, 7% acetic acid for 30 minutes.
The gels were stained with SYPRO Ruby (Invitrogen) overnight and washed in 10%
methanol, 7% acetic acid for 60 minutes followed by dH20 the next morning.  They were
imaged on a Typhoon 9410 fluorescent scanner (GE Healthcare Life Sciences,
Piscataway, NJ) for quantitative analysis and then stained with Simply Blue Coomassie
(Invitrogen) overnight to allow hand picking of spots.
Software Analysis:  For the protein spot detection Phoretix 2D Expression
software (Nonlinear Dynamics; Nonlinear USA, Durham, NC) was used.  Gels were
warped and spots matched automatically by the program but matching was manually
checked on all gels and adjusted to correct for incorrect matches. All gels were
scrutinized to ensure accurate spot detection, matching and that artifacts were not counted
as actual spots.  Three replicates of each age were grouped together to make an average
gel for that age.  Spots present on at least two of the three gels were included on the
average gel for that age group.  Expression values for each spot were expressed as protein
spot volumes.  Background subtraction was employed using the Mode of Non-Spot
(default) at a margin of 45 (default). The spot volume was normalized to total spot
volume on its average gel.
Clustering of Data: To cluster the data, we used the SOM (Self-Organizing
Maps) method provided by the GeneCluster 2.0 3.  Available at
 http://www.broad.mit.edu/cancer/software/genecluster2/gc2.html.  To preprocess the
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data, we replaced missing expression values with 0s, interpreting a missing expression
value as an absence of a signal, and normalized the data to mean of 0 and variance of 1.
The SOM algorithm was executed with the desired cluster range of 6 and the rest of the
parameters left unchanged (50000 iterations, seed range of 42, initialization of centroids
to random vectors, bubble neighborhood, initial and final learning weights of .1 and .005,
and initial and final sigmas determining the size of the update neighborhood of a centroid
set to 5 and .5, respectively). This produced 6 clusters with the peak at each time point.
Spot Picking and Identification of Proteins:  For protein identification, gels
were stained with SimplyBlue (Invitrogen).  Spots of interest were hand picked based on
clustering results and maps from Phoretix software analysis. Trypsin digestion and
deposition to a target for MALDI were performed using an Ettan Spot Handling
Workstation (Amersham Biosciences, Newark, NJ, USA).  For MALDI analysis, the
tryptic peptides dissolved in 50% CH3CN/0.1% TFA were mixed with a matrix solution
(CHCA 10 mg/mL in 50% CH3CN/0.1% TFA) and applied on a target plate. For ESI
experiments, protein digest solution was taken out after trypsin digestion, extracted and
dried to needed volume.
MALDI-TOF MS/MS MS analyses were performed using a QSTAR XL
quadrupole TOF mass spectrometer (AB/MDS Sciex, Toronto, Canada) equipped with an
MALDI ion source. The mass spectrometer was operated in the positive ion mode. Mass
spectra for MS analysis were acquired over m/z 500 to 4000. After every regular MS
acquisition, MS/MS acquisition was performed against most intensive ions. The
molecular ions were selected by information dependent acquiring in the quadrupole
analyzer and fragmented in the collision cell.  For ESI Mass Spectrometry the peptide
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digest samples were introduced to the QSTAR XL quadrupole TOF mass spectrometer
with a Switchos LC pump and a FAMOS autosampler (LC Packings, San Francisco,
USA). Other parameters of the mass spectrometer were the same as MALDI analysis.
All spectra were processed by MASCOT (MatrixScience, London, UK) database
search. Peak lists were generated by Analyst QS (AB/MDS Sciex, Toronto, Canada) and
were used for MS/MS ion searches. Typical search parameters were as follows:  Max
missing cleavage is one, fixed modification carboxyamidomethyl cysteine, variable
modification oxidation of Methionine. Peptide mass tolerances were +/- 100 ppm.
Fragment mass tolerances were +/- 1 Da. No restrictions on protein molecular weight
were applied. Protein identification was based on the probability based Mowse Score.
The significance threshold p was set to less than 0.05.
Gene Ontology (GO analysis): GO Tree Machine (GOTM; 4) was used to return
the GO categories for each of the clusters.  If any level 3 category appeared more than
once, the additional copies were removed.
2.4 Results
As an initial step to better understand rod photoreceptor development we profiled
the proteome of the developing mouse retina during the time of maximal rod
photoreceptor genesis and cell fate determination.  To make the expression analysis more
robust, we analyzed retinas from ages E13, E15, E17 E18 P0 and P5.  Representative gels
from each age are shown in figure 1.  Quantitatively, each age gel is a composite gel
made up of three replicate gels.  Spots on composite gels from each age were matched
across ages.  To control for slight loading, staining or scanning differences, expression
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levels for each spot were normalized and expressed as a percentage of the total signal
(spot volume) for each gel.  Expression values were used to cluster spots based on their
changing levels of expression from E13 to P5.  Figure 2 shows the results from Gene
Cluster when 6 clusters were pre-specified.  The resulting clusters contained groups of
proteins that had their peak in expression at each of the ages examined.   For this
analysis, we were most interested in the clusters that contained proteins that peaked at
E17, which is just prior to the peak of rod photoreceptor genesis, P0 which is at the peak
of rod photoreceptor genesis and P5, which is past the time of rod genesis, but the time
when early, irreversible rod differentiation is occurring.
Based on the clustering analysis, spots in cluster 1 (c1; expression peaked at E17),
c4 (expression peaked at P0) and c0 (expression peaked at P5) were hand-picked for
identification.  Of the spots that were picked for analysis, 71.1% (170/239) returned high
probability IDs that could be confirmed based on known or predicted molecular weights
and isoelectric focus points (pIs).  Twenty-three proteins were represented by more than
one protein spot. Tables 1, 2 and 3 list the 107 distinct proteins that peaked at E17, P1
and P5 respectively.  Gene ontology (GO) annotations for the 107 proteins were retrieved
using GO Tree Machine 4.  Ontologies at level 3, that is, three branch points in from the
top-level ontologies of cellular localization, molecular function and biological process,
were tallied. The most highly represented categories in the cellular component branch
were intracellular compartment and intracellular organelle.  The most highly represented
molecular function categories were protein binding, nucleic acid binding, nucleotide
binding and ion binding.  The most highly represented biological process categories were
metabolism, cellular physiological process, localization and cell communication  (data
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not shown).
To better understand the proteins that were identified in this analysis, we did a
manual literature search to look for published links between each protein and retinal
development, retina, CNS development, CNS and finally any published link to cancer.
Figure 3a illustrates the number of proteins in our analysis with previously published
links to the indicated criteria and that peaked at E17.  Of 60 proteins in the cluster, 44
were positively identified.  Based on a search of the literature, 3 proteins had been
previously linked to retinal development, 10 to retina, 5 to CNS development, 13 to CNS,
and 13 had been previously linked to cancer. Fifteen of the proteins had no published link
to any of the search criteria.  These data are also represented in table 1.  Figure 3b
summarizes the published links between criteria terms and proteins in our analysis that
peaked at P0.  Of 56 protein spots in the cluster, 21 were identified.  Based on a search of
the literature, 1 had been previously linked to retinal development, 6 to retina, 1 to CNS
development, 2 to CNS, and 10 to cancer.  Seven proteins had no published link to
criteria terms.  These data are also represented in table 2.  Figure 3c summarizes the
published links between criteria terms and proteins in our analysis that peaked at P5.  Of
123 protein spots in the cluster 102 were identified.  Based on a search of the literature, 9
had been previously linked to retinal development, 17 to retina, 11 to CNS development,
16 to CNS, and 35 to cancer.  Twenty-four of the proteins had no previously published
link to the criteria terms.  These data are also represented in table 3.
This analysis identified 107 distinct proteins that are dynamically expressed in the
retina during rod photoreceptor development.  Of these proteins, 23 were represented by
more than one protein spot, suggesting they are dynamically post-translationally
41
modified.  Finally, a manual search of the published literature identified prior published
reports had already linked 11 of the 107 proteins to retinal development in some way.
Thus, we have identified dynamic expression and/or modification of 96 proteins that had
not been previously described in the developing retina.
2.5 Discussion
We have used protein expression profiling to identify proteins that are
dynamically expressed during rod genesis.  Our analysis of the developing mouse retina
focused on proteins that peaked in expression at E17, immediately prior to the peak of
rod genesis, P0 during the peak of rod genesis and at P5, when the majority of newly
born rods are differentiating. Our analysis identified proteins spots that peaked at each of
these three ages.  Of these dynamically expressed proteins, some of them have been
described previously in the developing retina.
At age E17, an age before the majority of rods are born, we identified 3 proteins
that peaked in expression at E17 that have been previously described in the developing
retina.  These proteins are fructose-bisphosphate aldolase A, ras-related protein Rab-11A
and stathmin.
Fructose-bisphosphate aldolase A, is a member of the class I fructose-
bisphosphate aldolase family and is involved in pathways including glycolysis and
carbohydrate degradation 5.  This protein has been putatively linked to retinoblastoma in
fetal retina 6.  It should be noted that we identified 4 fructose-bisphosphate aldolase A
spots in our analysis, one spot peaked in expression at E17, and three others that peaked
at P5.  This can be explained by the presence of post-translational modifications (PTMs)
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to the protein.  We did not identify which PTMs are present in the developing retina,
however it has been reported that one PTM, tyrosine nitration, impairs mammalian
aldolase A activity 7.
Stathmin (phosphoprotein p19) is a phosphoprotein located in the cytoplasm and
is ubiquitously expressed 8. It functions to destabilize the microtubule system 8.  In a
study of the developing rat retina stathmin mRNA was highly expressed in retinal
ganglion cells and interneurons 9.  We identified 4 stathmin spots in our analysis.  Two
spots peaked at E17 and two peaked at P0.  Beretta and colleagues 10 identified four
potential phosphorylation sites and have observed 14 molecular forms of stathmin on 2D
gels .  Of the 14 stathmin spots they identified 2 were unphosphorylated and 12 were
phosphorylated on one or more sites, however the functional significance of these
phosphorylation sites is not clear.
Ras-related protein Rab-11A is a peripheral membrane protein that modulates
endosome trafficking and is a GTP binding protein belonging to the GTPase superfamily.
Rab-11, has been shown to be required for proper Drosophila eye development 11.  Rab11
is synthesized during larval development by the photoreceptors and becomes localized to
rhabdomeres and lamina neuropil in the adult.  In one Rab 11 mutant strain the
photoreceptors and bristles failed to form.  Its dynamic expression in our analysis
suggests it may be important for mammalian retinal development as well.
Rod genesis in the mouse retina peaks near P0 12.  In our analysis of the 22
identified protein spots that peaked at P0, only one, stathmin, has been previously
described in developing retina.  As previously discussed, stathmin is shown to be highly
expressed in developing ganglion cells and interneurons.  Two stathmin spots were
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identified as peaking at P0 representing post-translational modifications suggesting that
the role of this protein during retinal development may be dependent on its modification.
Of the ages examined in this analysis, P5 is after the peak of rod photoreceptor
genesis and at a time when we would expect many rod photoreceptors to be
differentiating.  Of the 103 identified protein spots that peaked at P5, we were able to find
published reports previously linking 10 of them to retinal development.  These proteins
include fructose bisphosphate aldolase A which has been discussed previously.  In
addition, calretinin, eukaryotic translation initiation factor 4B, fatty acid-binding protein
(epidermal), myosin light polypeptide 6, phosphoglycerate kinase 1, retinol-binding
protein I (cellular), SET protein and vimentin were proteins that peaked at P5 in our
analysis and have been previously reported in the developing retina.
Calretinin (calbindin 2) is a calcium binding protein that is widely expressed in
the retina and developing CNS 13.  It’s increased expression likely represents the
maturation of the retina in this analysis.  Vimentin is expressed in retinal progenitor cells
early in development 14 and only in Müller glia later in the mature retina 15.  Our
identification of the presence of vimentin spots, is perhaps more confirmatory and does
not necessarily add to the body of knowledge of retinal development.
Eukaryotic translation initiation factor 4B is needed to bind mRNA to ribosomes
16.  When expressed in a cultured Drosophila cells, eIF4B is required for cell survival and
over expression in eye imaginal discs promotes cell proliferation 17.  Our observation of
the increasing expression in the P5 retina may suggest it is acting as a survival factor as
cells differentiate.
Fatty acid-binding protein (epidermal) is localized to the cytoplasm and has a high
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affinity for fatty-acids18.  In the rat retina, the protein is involved in axonal elongation of
retinal ganglion cells during development. 19.  Previous studies have also suggested that
FABP is involved in synapse formation 20, which would be consistent with an increasing
expression in the P5 retina, at which time the retinal cells are forming synapses.
Fatty-acid binding protein, brain (B-FABP) is a member of a family of small
cytoplasmic proteins that bind hydrophobic ligands.  Expression patterns of B-FABP in
the developing nervous system suggest it may play a role in neurogenesis or neural
migration 21.  In addition to the developing brain B-FABP expression has been reported
in the human fetal retina 22.
Myosin light polypeptide 6 plays a role in retinal ganglion cell growth cone
motility in Xenopus 23.  Presumably there is little RGC growth cone motility in the P5
retina, suggesting it is perhaps involved in other remodeling events occurring in the P5
mouse retina.
SET protein is found in the cytoplasm, nucleus and endoplasmic reticulum.  It is a
multitasking protein involved in functions such as transcription, apoptosis and
nucleosome assembly 24.  High levels of SET have been described in the developing
mouse retina, particularly in the nucleus suggesting that it may play a role in cell
proliferation25.  However, in our analysis, we observed a peak in the expression of this
protein spot when cell division is almost complete, perhaps suggesting an additional role
for the protein during retinal development.
Retinol-binding protein (cellular) functions to transport retinol intracellularly 26.
Its expression has been described in the developing retina and RPE in mouse 27.
Expression of retinol-binding protein has also been reported in the embryonic mouse
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brain suggesting a role in CNS development 28.
A number of important studies have used expression analysis to identify genes or
proteins expressed during retinal development 29-33.  The motivation behind this approach
is two-fold.  Firstly, molecules important for particular events during retinal
development, may be expected to change at the time that said event is occurring.
Secondly, profiling genes that change in relation to one another may help investigators to
identify pathways or groups of genes that work together during retinal development.
Protein expression profiling can be a powerful compliment to mRNA expression analysis.
Changes in protein expression are a more definitive measure of how much gene product
is present in cells.  However, the most powerful compliment that 2D gel expression
analysis offers is the ability to capture not only changes in expression but also changes in
post-translational modification.  The existence of post-translational modifications can be
discovered by differences in pI or molecular weight.  In our analysis alone, we identified
23 proteins with dynamic post-translational modifications.  In future experiments specific
dyes for phosphorylation and glycosylation may be useful to identify and quantify
specific post-translational modifications.
A recently published complementary study used 2D-gel electrophoresis to profile
dynamic changes in protein expression in the postnatal mouse retina 33. In this study they
identified 174 total protein spots. Of the 170 total protein spots identified in this study
(E17, P0 and P5), 47 of them were in common with the previous study.  Differences may
be due to the different ages profiled as the previous study used strictly postnatal ages.
Protein expression profiling has also been successfully applied in the post-hatch chick
retina 34.  Even though these studies may have profiled different ages and/or species it
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still may be useful to integrate the information from these and other studies to generate a
more comprehensive profile of changes in protein expression during vertebrate retinal
development.
We have used protein expression profiling to characterize dynamic changes in
protein expression during rod photoreceptor genesis.  In this analysis we identified
proteins whose expression pattern peaked at E17, P0 or P5 (the oldest age profiled).  We
identified a number of proteins known to be important for rod development.  We also
identified several proteins that have a published role in CNS development but no other
link to the retina, making them potential candidates for further investigation.  Proteins
identified as dynamically expressed in the developing retina, that had have previously
reported to be expressed in various forms of cancer may also be an interesting group of
candidate proteins to pursue in relation to retinal cell differentiation.  Finally, there were
47 protein spots that have no previous published link to retina or CNS development or
cancer. This group may also include a number of interesting candidate proteins that
would have otherwise, not likely ever been investigated.
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2.7 Figure Legends
Figure 1:  Representative images of gels from embryonic and postnatal retinal protein
samples.  Proteins were separated first by isoelectric focus point (pH 3-10) then by
molecular weight.
Figure 2:  Changes in protein expression across developmental time were used to cluster
protein spots into six groups.  Each group contained protein spots whose expression
peaked at a particular developmental age.  In each panel the y-axis represents relative
expression levels and the x-axis represents the ages analyzed.  Black dots represent ages
E13, E15, E17, E18, P0 and P5 from left to right respectively.  Gray lines represent one
standard deviation on either side of the mean expression pattern for each group of
proteins.
Figure 3:  Identities of dynamically expressed proteins whose expression peaked at E17
(A), P0 (B)and P5 (C) were used to search previously published literature.  Search criteria
terms were retina, retinal development, CNS, CNS development and cancer.
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2.8 Figures
Table 1.  Dynamically expressed retinal proteins that peaked at E17.
Primary
Accession
Number
(SwissProt)
A. Protein RetinalDevelopment Retina
CNS
Development CNS Cancer
P62259* 14-3-3 protein epsilon 35 36 36
P61982 14-3-3 protein gamma 37 37
Q8CAY6
Acetyl-CoA
acetyltransferase, cytosolic
(EC 2.3.1.9) 38
P24622 Alpha crystallin A chain 39
P17182* Alpha enolase (EC 4.2.1.11) 40
Q8VC30
BC021917 protein
(Dihydroxyacetone kinase)
Q9WVJ5* Beta crystallin B1
Q9JJU9 Beta crystallin B3
Q04447*
Creatine kinase B-type (EC
2.7.3.2) 41 41
O08614
Cytoskeletal protein
(synonym: utrophin) 42 42 43
Q8VCG1 Dutp protein
P05064*
Fructose-bisphosphate
aldolase A 6 6 6
P04344 Gamma crystallin B
P16858*
Glyceraldehyde-3-phosphate
dehydrogenase 44, 45 46
P63017*
Heat shock cognate 71 kDa
protein  47, 48
P49312*
Heterogeneous nuclear
ribonucleoprotein A1
(Helix-destabilizing protein) 49 50
Q8BG05*
Heterogeneous nuclear
ribonucleoprotein A3
O35737
Heterogeneous nuclear
ribonucleoprotein H
P61979*
Heterogeneous nuclear
ribonucleoprotein K 51
O88569*
Heterogeneous nuclear
ribonucleoproteins A2/B1 52 53
Q9D6R2
Isocitrate dehydrogenase
[NAD] subunit alpha,
mitochondrial precursor (EC
1.1.1.41)
57
1.1.1.41)
P08249 Malate dehydrogenase,
mitochondrial precursor (EC
1.1.1.37) 54 54
Q6KAU2 MFLJ00025 protein
P25799
Nuclear factor NF-kappa-B
p105 subunit 55
P17742*
Peptidyl-prolyl cis-trans
isomerase A (EC 5.2.1.8) 56 57
Q5SPL2 PHD finger protein 12
Q9DBJ1
Phosphoglycerate mutase 1
(EC 5.4.2.1) 58
P17918
Proliferating cell nuclear
antigen (PCNA) (Cyclin) 59
Q9QUM9
Proteasome subunit alpha
type 6 (EC 3.4.25.1)
P09103*
Protein disulfide-isomerase
precursor (EC 5.3.4.1) 60
Q5HZG6 Psmd1 protein
P62492 Ras-related protein Rab-11A 11 11 11 61 62
Q8K2T1 RIKEN cDNA 1110025F24
Q8R0I6 RIKEN cDNA 1700023O11
P54227*
Stathmin (Phosphoprotein
p19) 9 63 64 65
P68369* Tubulin alpha-1 chain 66 66 67
P68372* Tubulin beta-2c chain
Q9D486
Adult male testis cDNA,
RIKEN full-length enriched
library, clone:4933407C03
product:hypothetical PH
domain-like/RNI-like
structure containing protein,
full insert sequence
* Protein that was represented on a gel by more than one spot.
Numbers indicate references used to link the protein to a particular search criteria.
Table 1 (cont)
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Table 2.  Dynamically expressed retinal proteins that peaked at P0.
Primary
Accession
number
(SwissProt)
Protein RetinalDevelopment
R
e
t
i
n
a
CNS
Development CNS Cancer
P60710*
Actin, cytoplasmic 1 (Beta-
actin) 68
P17182* Alpha enolase 40
P16460
Argininosuccinate synthase
(EC 6.3.4.5) (Citrulline--
aspartate ligase) 69, 70
Q6WKZ7 Dab2-interacting protein 2
Q8VHX2
Ectodysplasin A receptor
associated adapter protein
P19157
Glutathione S-transferase P
1 71, 72
O09131
Glutathione transferase
omega 1 73
Q8CDU5
Mus musculus adult male
testis cDNA, RIKEN full-
length enriched library,
clone:4921525D22
Q8C0Q7
Mus musculus adult male
testis cDNA, RIKEN full-
length enriched library,
clone:4932416A11
Q61937
Nucleophosmin (NPM)
(Nucleolar phosphoprotein
B23) (Numatrin) 74
P17742*
Peptidyl-prolyl cis-trans
isomerase A (EC 5.2.1.8) 57 56
P35700 Peroxiredoxin 1 75 76 76 77
Q9DBJ1
Phosphoglycerate mutase 1
(EC 5.4.2.1) 58
Q922R8
Protein disulfide-isomerase
A6 precursor (EC 5.3.4.1)
Q8C079 Protein FAM40A
P07724 Serum albumin precursor 78, 79
Q62421
SH3-containing GRB-like
protein 3
P54227*
Stathmin (Phosphoprotein
p19) 9 63 64 65
P63028
Translationally controlled
tumor protein (TCTP) (p23) 80
59
P17751 Triosephosphate isomerase
(EC 5.3.1.1) 58
* Protein that was represented on a gel by more than one spot.
Numbers indicate references used to link the protein to a particular search criteria.
Table 2 (cont)
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Table 3.  Dynamically expressed retinal proteins that peaked at P5.
Primary
Accession
number
(SwissProt)
Protein Name RetinalDevelopment Retina
CNS
Development CNS Cancer
P62259* 14-3-3 protein epsilon 35 36 35
P14206 40S ribosomal protein SA 81
P20029*
78 kDa glucose-regulated
protein precursor (GRP 78) 82, 83 84 85
P97819
85 kDa calcium-
independent phospholipase
A2 (EC 3.1.1.4)
P60710*
Actin, cytoplasmic 1 (Beta-
actin) 68
Q3U0V1
Activated spleen cDNA,
RIKEN full-length enriched
library, clone:F830029A18
product:KH-typ
P17182* Alpha-enolase (EC 4.2.1.11) 40
P62996
Arginine/serine-rich
splicing factor 10
Q08331 Calretinin 86 87, 88 89 89 90
P67871
Casein kinase II beta
subunit 91, 92
Q3UHL8
CDNA, RIKEN full-length
enriched library,
clone:M5C1012D21
product:leucine zipper
transcription factor-like
1full insert sequence
[Fragment]
Q60972*
Chromatin assembly factor
1 subunit C
Q04447*
Creatine kinase B-type (EC
2.7.3.2) 41 41
Q62188
Dihydropyrimidinase-
related protein 3 (DRP-3) 93 93
Q99LX0 DJ-1 protein 94 95, 96
Q8BL66 Early endosome antigen 1
P08113* Endoplasmin precursor 97
Q9QV38
ERP61, GRP58= STRESS-
inducible LUMINAL
endoplasmic reticulum
protein
Q8BGD9
Eukaryotic translation
initiation factor 4B (eIF-4B) 17 17
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P51880
Fatty acid-binding protein,
brain (B-FABP) 21, 22, 98 21, 22, 98
21,
22,
98 22
Q05816
Fatty acid-binding protein,
epidermal 19 99 100 100
101,
102
P05064*
Fructose- bisphosphate
aldolase A 6 6 6
Q9CWZ7
Gamma-soluble NSF
attachment protein (SNAP-
gamma)
P23818
Glutamate receptor 1
precursor (GluR-1) 103
103,
104
P63017*
Heat shock cognate 71 kDa
protein 47, 48
P07901
Heat shock protein HSP 90-
alpha
P49312*
Heterogeneous nuclear
ribonucleoprotein A1 49, 50
Q8BG05*
Heterogeneous nuclear
ribonucleoprotein A3
P61979
Heterogeneous nuclear
ribonucleoprotein K 51
O88569*
Heterogeneous nuclear
ribonucleoproteins A2/B1 52 53, 105
P10853* Histone H2B F
P97378
Interleukin-12 receptor beta-
2 chain precursor
Q9CPU0*
Lactoylglutathione lyase
(EC 4.4.1.5)
106,
107
P14733 Lamin B1 108-110
Q6ZQ34
MKIAA0850
protein
O54983
Mu-crystallin
homolog
Q60605 Myosin light polypeptide 6 23 23
Q62433
NDRG1 protein
(N-myc
downstream
regulated gene 1 protein) 111 112
111,
113
Q99LD8
NG,NG- dimethylarginine
dimethyl- aminohydrolase 2
(EC 3.5.3.18)
P09405* Nucleolin (Protein C23) 114
115,
116
P28656*
Nucleosome assembly
protein 1-like 1 117
P17742* Peptidyl-prolyl cis-trans
isomerase A (EC 5.2.1.8)
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isomerase A (EC 5.2.1.8)
Q61171*
Peroxiredoxin 2 (EC
1.11.1.15) 75 76 76 118
P70296
Phosphatidyl ethanolamine-
binding protein 119
P09411
Phosphoglycerate kinase 1
(EC 2.7.2.3)
120,
121 122
Q9R1P1
Proteasome subunit beta
type 3 (EC 3.4.25.1) 123
Q9CSU0 Protein C20orf77 homolog
Q4G0D4
Protein phosphatase 4,
regulatory subunit 2
P52480*
Pyruvate kinase, isozyme
M2 (EC 2.7.1.40) 124
Q00915
Retinol-binding protein I,
cellular 27 27 28, 125
28,
125 79
P07724 Serum albumin 126
Q9EQU5
SET protein (Phosphatase
2A inhibitor I2PP2A) 25 25 127
Q9JJU8
SH3 domain-binding
glutamic acid-rich-like
protein
P70297
Signal transducing adapter
molecule 1
Q64674
Spermidine synthase (EC
2.5.1.16) 128
Q8BL97
Splicing factor,
arginine/serine-rich 7
Q12931
TNF receptor associated
factor 1 129
Q6PFR5
Transformer-2 protein
homolog (TRA-2 alpha)
Q01853
Transitional endoplasmic
reticulum ATPase
P68369*
Tubulin alpha-1 chain
(Alpha-tubulin 1) 66 66 67
P68372* Tubulin beta-2c chain
P99024* Tubulin beta-5 chain 130 67
Q8R317 Ubiquilin-1 131
P61089
Ubiquitin-conjugating
enzyme E2 N (EC 6.3.2.19) 132 133
Q9DBP5
UMP-CMP kinase (EC
2.7.4.14) 134
P20152 Vimentin 14, 135 135 135 135 135
* Protein that was represented on a gel by more than one spot.
Numbers indicate references used to link the protein to a particular search
criteria.
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CHAPTER 3: THE ROLE OF MAMMALIAN TARGET OF RAPAMYCIN
(mTOR) IN PHOTORECEPTOR DEVELOPMENT IN THE RETINA
A paper to be submitted to Vision Research
A.E. Barnhilla,b, L.A. Heckerd and M.H. West Greenleea,b,c
aNeuroscience Interdepartmental Program, bDepartment of Biomedical Sciences,
cBioinformatics and Computational Biology Program, Iowa State University, Ames Iowa,
dMayo Clinic, Rochester Minnesota
3.1 Abstract
Currently the exact mechanism by which a photoreceptor chooses its cell fate is not
completely understood.  Biasing cells to a rod photoreceptor cell fate has the potential to
improve vision in patients afflicted with photoreceptor degenerative diseases.  We have
previously observed that insulin-like growth factor-1 (IGF-1) promoted rod
differentiation. Mammalian target of rapamycin (mTOR) is a molecule downstream of
IGF-1 signaling.   In order to investigate the potential role of (mTOR) signaling during
rod photoreceptor differentiation we examined the developmental expression of mTOR
during retinal development. We characterized the developmental distribution of mTOR
and its binding partners, raptor and rictor in the developing mouse retina using
immunohistochemistry.   mTOR is present throughout the developing and mature retina
as are raptor and rictor.  Next we tested the functional significance of mTOR during
development. We cultured developing murine retinal explants with an mTOR inhibitor,
rapamycin for 10 days.  Inhibition of mTOR in E17, but not P0 explants increased rod
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photoreceptor differentiation by approximately 20%.  Our results suggest that mTOR is
important in modulating differentiation of rod photoreceptor cells.
Keywords: Development, Retina, Mouse, Photoreceptor, mTOR
3.2 Introduction
Diseases of the retina cause loss of vision and can lead to blindness. Diseases such as
macular degeneration and retinitis pigmentosa are the result of photoreceptor
degeneration.  Age related macular degeneration (AMD) is the number one cause of
blindness in retirement aged Americans (Ambati et al. 2003) and is a growing concern as
the population ages.  The loss of sight will hinder the ability to be self sufficient and live
independently as well as have an economic impact with increased dependent care
situations.  Since photoreceptors cannot be regenerated, cell transplantation to replace
degenerate photoreceptors is a potential approach to regaining loss of vision in these
individuals.
Successful cell transplantations with appropriate spatial and functional integration
into the host retina are necessary if we hope to restore vision to those afflicted with
blinding retinal diseases. Various neural progenitor cell types have been transplanted into
the retina including retinal progenitor cells (RPCs) (Klassen et al. 2004; Qiu et al. 2005)
brain progenitor cells (BPCs) (Lu et al. 2002; Mizumoto et al. 2003; Sakaguchi et al.
2003), adult hippocampal progenitor cells (AHPCs) (Nishida et al. 2000; Takahashi et al.
1998; Young et al. 2000) and iris-derived/ciliary body cells (Ahmad et al. 2004; Ahmad
et al. 2000; Tropepe et al. 2000).
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The only example to date of successful photoreceptor transplantation with
differentiation and functional integration into the host retina utilized cells that had already
begun to express Nrl, an early marker of photoreceptor cell fate commitment (MacLaren
et al. 2006).  Cells transplanted prior to rod cell fate commitment did not successfully
integrate suggesting that in order to achieve success cells must first be biased to the
desired cell fate. Thus, based on current information it appears that in order to effectively
transplant cells and have them incorporate into the retina it is necessary to be able to bias
them to a photoreceptor cell fate.  Therefore, studies to better understand the mechanisms
controlling cell fate determination in the developing retina may provide valuable
information towards this end.
A Target of Rapamycin (TOR) molecule, present in Drosophila (dTOR) has been
reported to have an effect on photoreceptor development in the metazoan eye via the Tsc-
1 protein (Bateman and McNeill 2004).  A mutagenesis screen revealed mutated Tsc-1
protein in abnormal eye patterning in Drosophila.  Tsc-1 protein is downstream in insulin
and TOR signaling pathways.
Mammalian TOR(mTOR) molecules are 235kDa Phosphatidylinositol kinase (PIK)-
related kinases with multiple functions in cell growth and proliferation (Sarbassov et al.
2005a).  There are two binding complexes for mTOR.  mTORC1’s (mTOR/Raptor
complex) major role is in controlling cell growth (cell size) (Schmelzle and Hall 2000).
mTORC2’s (mTOR/rictor complex) role is controlling cellular proliferation, cytoskeletal
organization and microtubule growth (Swiech et al. 2008).
mTOR can be activated by IGF-1 signaling (Oldham and Hafen 2003).  Previous
studies have demonstrated that
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application of IGF-1 to cultured retinal explants increases rod photoreceptor
differentiation (Hecker and Greenlee, Personal Communication).  To investigate the
potential role for mTOR in retinal development, we characterized the expression of
mTOR and two of its binding partners, raptor and rictor in the developing mouse retina.
To determine if mTOR has a role specifically in photoreceptor development, we inhibited
mTOR in developing retina using rapamycin, a specific inhibitor of mTOR/raptor
complex and assayed rod photoreceptor differentiation.  Our results demonstrate that
mTOR and its binding partner rapamycin is expressed in developing and mature
photoreceptors.  Further, our results demonstrate that inhibition of mTORC1
(mTOR/raptor) decreases rod photoreceptor differentiation.
3.3 Materials and Methods
Animals and Tissue Preparation
C57BL/6 mice were obtained from a colony maintained at Iowa State University.  The
date of birth is designated as postnatal day 0 (P0).  Mice ages E15 to P5 were euthanized,
their heads were removed and immersion fixed in 4% paraformaldehyde in 0.1M PO4
buffer (pH 7.5).  Postnatal day 10 and adult mice were euthanized and their globes were
immersion fixed in 4% paraformaldehyde.  The tissue was cryoprotected in a 30%
sucrose solution in 0.1 M PO4 buffer (pH 7.4), embedded in OCT and sectioned at a
thickness of 20 µm.    For retinal explant culture, eyes were removed from E17 and P0
heads for dissection.  All animal procedures were in adherence to the ARVO statement
for the use of Animals in Ophthalmic and Vision Research had the approval of the ISU
committee on animal care.
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Antibodies
All primary antibodies were diluted in blocking solution (potassium phosphate buffered
saline (KPBS; 0.15 M NaCl, 0.034 M K2HPO4, 0.017 M KH2PO4, pH 7.4) containing 1%
BSA, 0.4% Triton-X 100, and 1.5% Normal Donkey Serum (NDS, Jackson
ImmunoResearch Laboratory, West Grove, PA).  Rabbit polyclonal anti-mTOR antibody
(Bethyl Laboratories, Inc., Montgomery, TX) was diluted 1:20.  Mouse monoclonal anti-
rhodopsin antibody (a generous gift from Dr. Colin Barnstable, Yale University) was
diluted 1:250.  Rabbit polyclonal anti-raptor (Bethyl Laboratories, Inc., Montgomery,
TX) was diluted 1:50. Rabbit polyclonal anti-rictor (Bethyl Laboratories, Inc.,
Montgomery, TX) was diluted 1:100.  The fluorescent secondary antibodies Alexa
Fluor® 594 donkey-anti mouse and Alexa Fluor® 594 donkey-anti rabbit (Molecular
Probes, Eugene, OR) were diluted 1:500.  Secondary antibodies were diluted in KPBS
containing 1% BSA, 1.5% NDS, and 0.02% Triton-X 100.
Immunohistochemistry
Frozen tissue sections or dissociated retinal cells (adhered to slides and fixed) were rinsed
in 0.5M KPBS and incubated in blocking solution.  Slides were incubated in primary
antibody overnight at 4ºC.  The following day slides were washed in KPBS containing
0.02% Triton-X 100 after which fluorescent secondary antibody was applied.  Prior to
cover-slipping, the slides were incubated in 300 µM DAPI diluted in KPBS.
Retinal Explant Culture
The explant culture procedure was adapted from Zhao and Barnstable (Zhao and
Barnstable 1996).  Briefly, eyes from E17 and P0 pups were dissected in culture media
and whole retinae with lenses intact were isolated away from the RPE.  One retina, lens
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face up, was added to each well of a 24 well plate with 1 mL of culture media
(UltraCulture (Cambrex, East Rutherford, New Jersey) with 2 mM L-glutamine
(Invitrogen, Carlsbad, CA) and 10 µg/mL of gentamycin (Invitrogen).  After 10 days in
culture the explants were harvested.  Rapamycin (Calbiochem, San Diego, CA), an
mTOR inhibitor was added to the UltraCulture media before use at a concentration of 0.1,
1 or 5 µM for E17 explants and 1µM for P0 explants.  An equal amount of vehicle
(dimethyl sulfoxide) was added to control explants.
Cell Dissociation
At the termination of the experiment, lenses were dissected from the eyes.
Following lens removal, 2 retinas per experimental condition were collected and washed
in sterile phosphate buffered saline (PBS; 14 mM NaCl, 2.7 mM KCl, 5.37 mM
Na2HPO4, 1.76 mM KH2PO4).  Tissue was incubated at 37ºC for 5 minutes in PBS
containing 0.25% trypsin (Invitrogen) and titrated with a glass pipette to generate a single
cell suspension.  The cells were centrifuged and re-suspended in PBS with 0.0025%
trypsin inhibitor (Invitrogen) and incubated at 37ºC for 5 minutes.  Cells were re-
suspended in explant culture media.  The cells were transferred to 0.01% poly-L-lysine
(Sigma, St. Louis, MO) coated 8 well chamber slides (Nalge Nunc International,
Rochester, NY) and incubated at 37ºC for 30 minutes prior to fixation and analysis.
Cell counting
For each experimental condition, 2 explanted retinas were placed in a centrifuge
tube containing 2 mls of UltraCulture media.  The number of cells in each explant culture
condition was approximated following dissociation of the retinal explants, by
determining density of cells (from known number of explants) in a known volume of
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media.  For obtaining percentages of cells expressing rod photoreceptor markers, cells
were counted using a fluorescence microscope with a 20x objective.  Ten fields in each
chamber of each 8 well chamber slide were counted.
Statistical analysis
Analysis of the statistical significance of the observed differences between
treatments in retinal explant culture was done using SUPERANOVA software (Abacus
Concepts, Berkeley, CA).  Tukey-Kramer (All means) and Bonferroni-Dunn (all means)
tests were performed at a significance level of 0.05.  Values are expressed as means ±
SEM.
Microscopy
Tissue sections were imaged with a Nikon fluorescence microscope (Nikon
Instruments, Melville, NY) equipped with a Retiga 1300 digital camera (QImaging,
Burnaby, BC, Canada). Adobe Photoshop version 9 (Adobe Systems Incorporated, San
Jose, CA) was used to crop images and Macromedia Freehand 11 (Macromedia
Incorporated, San Francisco, CA) software was used to prepare figures.
Hyperspectral microscope
The Spectral DV (Optical Insights) hyperspectral microscope attached to a Nikon
TE2000-E equipped with a Roper Scientific Cascade 512B camera at the Roy J. Carver
laboratory for Ultrahigh Resolution Biological Microscopy (Iowa State University,
Ames, Iowa) was used to image immunolabeled slides.  All fluorescent antibodies, GFP
tissue sections, wild type tissue sections and DAPI were imaged to determine their
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spectral fingerprints for inclusion in the software’s database.  The Tri Filter was used for
all experiments.  The experimental slides were analyzed and the dark offset removed.
The wavelength signatures on the corrected data were plotted and extracted. The plots
were then added to the database.
Images analysis was done using Melange Spectral Imaging Software, version 3.4.0
(Optical Insights, LLC).  After the dark offset was removed, the corrected data was
spectrally unmixed using the spectral definition supplied and each individual fluorophore
contribution to the image was extracted.  Files were separated and saved.  A color overlay
was done and colors were assigned for the antibodies of interest.  Any fluorophore can be
included or removed as desired. Autofluorescence was removed to facilitate visualization
of the antibodies of interest.
3.4 Results
To determine the developmental distribution of mTOR in the retina, we used
immunohistochemistry to examine mTOR immunoreactivity in retinal tissue sections
from animals, ages embryonic day (E) 15, E17, postnatal day (P) 0, P5, P10 and adult.
mTOR immunoreactivity in the retina
At E15 (Figure 1A) the retina is still largely unlaminated consisting primarily of
neuroepithelial cells. At this age, mTOR-immunoreactivity (mTOR-IR) was diffuse
throughout the retina, and was more intense in the developing ganglion cell layer (GCL).
Similarly, mTOR-IR in the E17 (Figure 1B) retina was diffuse throughout the retina, with
more intense mTOR-IR in the inner one-third of the retina.  In the P0 mouse retina
(Figure 1C), the inner plexiform layer (IPL) is morphologically recognizable.   mTOR-IR
74
was diffusely distributed throughout the retina.  In addition, more intense mTOR-IR in
cells adjacent to the RPE was visible (asterisks).  Diffuse mTOR-IR persisted in the
postnatal day 5 retina (Figure 1D).  The most intense mTOR-IR was present in the GCL
and the inner portion of the inner nuclear layer (INL).  The outer one-half of the retina,
the presumptive outer nuclear layer (ONL) was also moderately immunoreactive, while
the IPL and outer plexiform layer (OPL) were devoid of immunoreactivity. The intense
mTOR-IR adjacent to the RPE also seen in P0 persisted in the P5 retina (asterisks).  In
the P10 retina (Figure 1E), the diffuse mTOR-IR present throughout the retina was less
intense than at earlier ages.  There were intense immunoreactive puncta in the GCL and
inner INL.  The developing OPL had fewer mTOR-IR puncta, and the ONL was
relatively devoid of mTOR-IR.  However, the intense mTOR-IR adjacent to the RPE,
presumably developing outer segments, was still present.  mTOR-IR in the mature retina
(Figure 1F) was most intense in the IPL, OPL and photoreceptor outer segments.
Relatively light mTOR-IR was observed in the OFL, GCL and INL, as were faint,
distinct, immunoreactive puncta were observed in the ONL.
In mature photoreceptors outer segments are often brightly autoflourescent.  We utilized
the hyperspectral microscope in order to distinguish mTOR immunoreactivity in the
photoreceptors from autofluorescence.  The hyperspectral microscope allows us to
separate spectra by spectral definition.  In the mature retina, with auto-fluorescence
removed, mTOR-IR was intense in the inner part of the photoreceptor outer segments
(Figure 2).
To determine which downstream targets of mTOR might be expressed in the
developing retina, we used immunohistochemistry to characterize the expression of two
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major binding partners of mTOR. We used immunohistochemistry to characterize
immunoreactivity for raptor and rictor the two major binding partners of mTOR
comprising the mTORC1 and mTORC2 complexes, respectively.
Raptor immunoreactivity in the retina 
At E15 in the undifferentiated retina (Figure 3A), raptor-IR was diffusely distributed but
appeared more intense in the developing ganglion cell layer.  Raptor-IR at E17 (Figure
3B) was similar to that observed at E15 with the most intense immunoreactivity in the
inner one third of the retina.  At birth (Figure 3C), the raptor-IR was diffusely distributed
throughout the retina with a more intense concentration in the inner third of the retina.
Occasional intense immunoreactivity was observed in the GCL.   Raptor-IR in the retina
at P5 (Figure 3D) was limited to the outer two thirds of the retina, the location of
differentiating photoreceptors.  By P10 (Figure 3D), however, raptor-IR could be
observed throughout the thickness of the retina, though the most intense
immunoreactivity was observed in the outer nuclear layer and the photoreceptor outer
segments.  In the adult retina (Figure 3E), Raptor-IR was diffusely distributed throughout
the retina with the most intense immunoreactivity in the IPL, OPL and photoreceptor
outer segments.
Rictor Immunoreactivity in the retina
Rictor-IR in the developing E15 (Figure 4A) retina was diffusely distributed but much
more intense in the presumptive GCL.  At E17 (Figure 4B), however, rictor-IR was
limited to the inner 1/4 of the retina, in the developing GCL.  At P0 (Figure 4C), once
again, rictor-IR was diffusely distributed with increased intensity in the GCL as well as
cells adjacent to the RPE (arrows).  At P5 (Figure 4D), Rictor-IR was diffuse throughout
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the retina but was most intense in the outer 3/4 of the retina including the developing INL
and ONL.  Rictor-IR at P10 (Figure 4E) was most intense in the GCL.  It was diffusely
distributed throughout the rest of the retina.  However, there was also an area of intense
Rictor-IR adjacent to the RPE.  In the mature retina (Figure 4F), Rictor-IR was most
intense in the GCL and the INL. It was present in the IPL and very faint in the ONL and
photoreceptor outer segments.
Functional role for mTOR in retinal development
To investigate the functional role of mTOR in mammalian photoreceptor differentiation
we inhibited mTOR, using rapamycin, in developing retinal explants for 10 days.  After
10 days retinas were dissociated and adhered to slides.  The slides were then processed
for rhodopsin immunoreactivity.  The effect of mTOR inhibition on rod photoreceptor
differentiation in retinal explants was assayed by counting cells immuno-positive for
rhodopsin (Figure 5). In the E17 retina, inhibition of mTOR with 0.1uM rapamycin
decreased rod photoreceptor differentiation by 19.3% when compared to the vehicle
control (p=0.0017).  Compared to control, 1uM rapamycin decreased rods by 16.2%
(p=.0083) and 5uM decreased rods by 28.8% (p=0.0001).  Though different from vehicle
control the differences between experimental groups did not reach statistical significance.
In addition, we assayed cell density and cell death in retinal explants to assess whether
the addition of rapamycin might be affecting cellular proliferation or cell survival
respectively.  There were no significant differences in cell density (p=0.95) or cell death
(p=0.29) between groups (Figure 6). To investigate the effect of mTOR inhibition at P0,
the peak of rod genesis, we assayed the effect of 1uM rapamycin on P0 retinal explants.
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However, inhibition of mTOR for 10 days did not significantly affect rod photoreceptor
differentiation in P0 explants (p=0.125; data not shown).
3.5 Discussion
Our results demonstrate that mTOR-immunoreactivity is present in developing
and mature photoreceptors suggesting that mTOR signaling may play an important role in
photoreceptor differentiation. The binding partners for mTOR, raptor (mTORC1) and
rictor (mTORC2) are both expressed in developing photoreceptors but only raptor was
expressed in mature photoreceptors.
To investigate the effect of mTOR inhibition on rod photoreceptor differentiation,
retinal explants from E17 and P0 mice were cultured in a defined medium and treated
with rapamycin for 10 days.  Expression of the rod specific photopigment, rhodopsin,
was used to assay rod differentiation.  In control cultures, 20% of the cells expressed
rhodopsin.  These values are well within the range of what has been reported by others
using a similar model system (Chen and Cepko 2007; Donovan and Dyer 2006; Zhang et
al. 2004b).   The developmental ages chosen for this study were based on their
importance in overall rod photoreceptor development.  In the E17 retina, there are
progenitors leaving the cell cycle and committing to the rod cell fate.  Rod photoreceptor
genesis does not peak, however, until P0 in the mouse.  Therefore, when rapamycin was
applied to E17 explants for 10 days, mTOR was inhibited in the majority of cells destined
to become rods prior to their exit from the cell cycle and commitment to a rod cell fate.
When rapamycin is applied to P0 retinal explants, however the majority of cells fated to
be rods would have already exited the cell cycle and committed to a rod cell fate before
mTOR was inhibited.  Inhibition of mTOR in E17 (but not P0) retinal explants for 10
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days resulted in an approximately 20% decrease in photoreceptor differentiation.  There
was no difference in explant cell density, or the number of dead cells in explants
immediately after dissociation, suggesting, albeit indirectly, that cell proliferation or cell
survival was not affected by rapamycin treatment.  This suggests that mTOR signaling
may mitigate rod photoreceptor differentiation prior to cell fate determination, as
inhibition of mTOR in P0 explants did not significantly affect rod differentiation.
The molecule mTOR has many different roles in cell growth and proliferation.
Downregulation of mTOR allows differentiation as shown in certain cell lines, vascular
smooth muscle and the CNS (Martin et al. 2007; Que et al. 2007; Swiech et al. 2008).  In
our experiments, however, mTOR activity appeared to promote photoreceptor
differentiation as inhibition of mTOR decreased rod differentiation.
The Drosophila homologue, dTOR was shown to have an effect on eye
development through the protein Tsc-1 as lack of signaling resulted in abnormal eye
patterning (Bateman and McNeill 2004).
The effect we induced is likely via mTORC1 (raptor) signaling since we get an
effect by adding rapamycin.  However a recent study demonstrates the rictor/mTOR
complex may be affected by rapamycin as well. This effect is due to the fact that
rapamycin eventually binds all the free mTOR. With all of the free mTOR bound, there is
no mTOR available to bind to rictor either (Sarbassov et al. 2006).
The IGF-1 signaling pathway when stimulated will increase photoreceptors
(personal communication, Hecker and Greenlee).  The mTOR molecule is downstream
from IGF-1 so the IGF-1 observed effect is potentially realized through mTOR signaling
as we observed a decrease in photoreceptor development with inhibition of mTOR.  To
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further test this hypothesis we would need to add both IGF-1 and rapamycin to our retinal
explant cultures.  If the increase in rod photoreceptor differentiation we observed is due
to the IGF-1 signaling pathway, we would expect rapamycin to attenuate or cancel out
the IGF-1 effect.
Presently, the mechanism by which a cell’s fate is determined in the retina is not
well understood. Many extrinsic factors have been investigated for their effect on retinal
development.  These include fibroblast growth factors, Sonic hedgehog (Levine et al.
1997), retinoic acid (Kelley et al. 1994), taurine (Altshuler et al. 1993; Wallace and
Jensen 1999; Young et al. 2005), 3-isobutyl-1-methylxanthine (Wallace and Jensen
1999), brain derived neurotrophic factor (Rohrer et al. 1999), leukemia inhibitory factor
(Neophytou et al. 1997) and ciliary neurotrophic factor (Ezzeddine et al. 1997).
However, it is still unclear how these factors interact with each other and at what ages
each is most influential (Reviewed in (Levine et al. 2000)).
Signaling of other molecules has been shown to modulate rod differentiation.
Examples demonstrated that the addition of, acidic fibroblast growth factor (FGF), basic
fibroblast growth factor (bFGF), taurine, Sonic Hedgehog protein (Shh) and retinoic acid
(RA) increased rod photoreceptor differentiation individually (Osakada et al. 2008).
Other studies have investigated individual factors and their effect on rod photoreceptor
differentiation.  FGF1 and FGF2 were some of the first identified factors shown to affect
rod photoreceptor differentiation.  These factors stimulated rhodopsin expression in rat
retinal cells cultured in vitro and increased the number of cells positive for rhodopsin
(Hicks and Courtois 1988; Hicks and Courtois 1992).  Additionally, FGF was found to
cause a proliferation in both rat monolayer cell cultures and retinal explants with
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progenitor cells from younger ages being more responsive to FGF (Lillien and Cepko
1992).
Similarly, Sonic hedgehog (Shh) was found to have a positive effect on rod
differentiation. When added to rat retinal cell cultures Shh resulted in an increase in the
number of differentiated rods (Levine et al. 1997). Retinoic acid (RA) is another extrinsic
factor that positively affects rod photoreceptor development.  Like Shh, when Retinoic
acid (RA) was added to dissociated rat retinal cells, the number of differentiated rods
increased (Kelley et al. 1994). Recently, another group demonstrated that RA affects rod
development by regulating Nrl (Khanna et al. 2006). They found that Nrl protein
increased in cultured rat and porcine photoreceptors as well as in Y79 cells, a human
retinoblastoma cell (Khanna et al. 2006).
Each of the aforementioned studies exerted an effect on rod differentiation by the
addition of an extrinsic factor. Conversely, in this study we inhibited a signaling pathway.
A logical next question would be whether or not we can excite this same pathway and
produce an opposite effect.  It has been previously demonstrated that the addition of IGF-
1 (a known activator of mTOR signaling) does promote rod photoreceptor differentiation
in developing retinal explants (Hecker and Greenlee, personal communications).  Studies
to test the hypothesis that the effect of IGF-1 is due to the activation of mTOR signaling
are underway.
Finally, it is possible that the increase in rod differentiation is at the expense of
the differentiation of other retinal cell types. The most likely cell types that would be
affected are predicted to be bipolar cells and Müller glia as they are two other ‘late born’
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cell types (Young 1985a).  We have not yet assayed the effect of mTOR inhibition on
differentiation of these alternate cell types.
Our findings indicate that mTOR is important in rod photoreceptor differentiation.
This study is the first study to demonstrate a modulatory role of mammalian TOR in
retinal development.  These results contribute to our understanding of rod cell fate
determination and differentiation.  Such an understanding may ultimately facilitate the
development of transplantation therapies to treat blinding diseases in which the ability to
influence retinal cell fate is crucial.
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3.7 Figure Legends
Figure 1: mTOR is expressed in the developing and mature mouse retina.  Expression of
mTOR in the C57/Bl6 wild type mouse at ages E15, E17, P0, P5, P10 and adult (A-F).
At E15 (A), mTOR-IR was intense in the developing GCL and there was less IR in the
NBL.  At E17 (B), mTOR-IR was very similar to that seen in E15.  In the P0 retina (C),
mTOR-IR was diffuse throughout the layers of the retina with an area adjacent to the
RPE with more intense IR (asterisks).   At P5 (D), mTOR immunoreactivity was
observed in the GCL, IPL, ONL and adjacent to the RPE (asterisks).  In the P10 retina
(E) mTOR-IR was observed in the GCL, IPL, OPL and the OS.  Immunoreactivity for
mTOR in the adult (F) retina was similar to P10 with intense labeling in the GCL, IPL,
OPL and the OS. Scale bars = 10mM.
Abbreviations: mTOR, Mammalian Target of Rapamycin; E, embryonic; P, post natal;
IR, immunoreactivity; GCL, Ganglion cell layer; RPE, retinal pigmented epithelium; IPL,
inner plexiform layer; OPL, outer plexiform layer; NBL, neuroblastic layer; OS, outer
segment; INL, inner nuclear layer; ONL, outer nuclear layer.
Figure 2: Wild type adult mice double labeled with mTOR (green) and rhodopsin (red).
In A, some autofluorescence was evident (asterisks).  In image B, autofluorescence and
all other fluorophores were removed except mTOR-IR (green). DAPI nuclear stain is
represented in blue. Rhodopsin-IR was observed in the rod photoreceptor outer segments.
mTOR-IR is more diffusely distributed and was seen in the inner segment, both
plexiform layers and the ganglion cell layer.
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Abbreviations: mTOR, Mammalian Target of Rapamycin; E, embryonic; P, post natal;
IR, immunoreactivity; GCL, Ganglion cell layer; RPE, retinal pigmented epithelium; IPL,
inner plexiform layer; OPL, outer plexiform layer; NBL, neuroblastic layer; OS, outer
segment; INL, inner nuclear layer; ONL, outer nuclear layer; DAPI, 4’,6-diamidino-2-
phenylindole.
Figure 3: Raptor, a binding partner of mTOR is expressed in the developing and mature
mouse retina. Expression of Raptor in the C57/Bl6 wild type mouse at ages E15, E17, P0,
P5, P10 and adult (A-F). In the E15 (A) retina, Raptor-IR was observed in the developing
GCL and throughout the NBL.  At E17 (B), Raptor-IR was present in the developing
GCL and the NBL.  In the P0 retina (C), Raptor-IR was in the GCL, IPL and NBL.  At P5
(D), Raptor-IR decreased in the GCL and was present in the IPL and ONL.  In the P10
retina (E), Raptor-IR was diffusely distributed with an increased intensity in the ONL and
OS.  In the adult retina (F), Raptor-IR was observed in the GCL, IPL, ONL and OS. Scale
bars = 10mM.
Abbreviations: mTOR, Mammalian Target of Rapamycin; E, embryonic; P, post natal;
IR, immunoreactivity; GCL, Ganglion cell layer; RPE, retinal pigmented epithelium; IPL,
inner plexiform layer; OPL, outer plexiform layer; NBL, neuroblastic layer; OS, outer
segment; INL, inner nuclear layer; ONL, outer nuclear layer.
Figure 4: Rictor, a binding partner of mTOR is expressed in developing and mature
mouse retina.  Expression of Rictor in the C57/Bl6 wild type mouse at ages E15, E17, P0,
P5, P10 and adult (A-F). In E15 (A) retina, Rictor-IR was intense in the GCL and
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moderately present in the NBL.  At E17 (B), Rictor-IR was similar to E15 with intense IR
in the GCL but decreased IR in the NBL.  At P0 (C), Rictor-IR persisted in the GCL and
was observed in the IPL and NBL.  In the P5 retina (D), IR was decreased in the GCL but
was observed in the IPL and ONL.  At P10 (E), Rictor-IR was again intense in the GCL
and present diffusely throughout the rest of the retina.  In the adult (F), Rictor-IR
persisted in the GCL with the most intensity and was present in the IPL. INL. ONL and
OS. Scale bars = 10mM.
Abbreviations: mTOR, Mammalian Target of Rapamycin; E, embryonic; P, post natal;
IR, immunoreactivity; GCL, Ganglion cell layer; RPE, retinal pigmented epithelium; IPL,
inner plexiform layer; OPL, outer plexiform layer; NBL, neuroblastic layer; OS, outer
segment; INL, inner nuclear layer; ONL, outer nuclear layer.
Figure 5: Inhibition of mTOR modulates rod photoreceptor differentiation.  Addition of
rapamycin to E17 retinal explants fro 10 days decreases rod photoreceptor differentiation.
All concentrations (0.1uM, 1uM and 5 uM) caused a significant decrease in rod
photoreceptors assayed by rhodopsin expression.  All groups were significantly different
from the control but not between concentrations. Asterisks indicate significance from the
control  (* p=0.0017, **p=0.0083, ***p=0.0001).
Figure 6: mTOR inhibition does not affect cell death in E17 retinal explants.  Addition of
rapamycin to E17 retinal explants for 10 days did not cause a significant decrease in cell
death as compared to control for all concentrations (0.1uM, 1uM and 5 uM).
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Figure 6
mTOR Inhibition Does not Affect Cell Death in E17 Retinal Explants
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CHAPTER 4: GENERAL CONCLUSIONS
4.1 Summary
My long term goal is to understand retinal development.  In my dissertation work
in particular, I wanted to begin to identify the factors that influence rod photoreceptor
development.  The answer to the question of how a rod becomes a rod holds potential for
understanding cell fate decisions broadly as well as biasing cell fate for successful cell
transplantations.
The approach we took for the experiments described in this thesis was twofold.
The first was a broad discovery based approach characterizing the proteins present during
normal mouse retinal development at 6 different ages, embryonic days 15 and 17, birth
(P0), post natal days (P) 5 and P10, using proteins expression profiling, specifically 2-
dimensional gel electrophoresis with MALDI-MS/MS protein identification.  The total
number of protein spots were quantified at each age and compared to the other ages for
intensity indicating relative quantities or spot volume.  These intensity values were
clustered based on normalized values. The protein spots chosen for identification were
the ones that peaked at ages E17, P0 and P5 because these are the ages important for rod
photoreceptor development. E17 is prior to the peak of rod photoreceptor birth, P0 is the
peak of genesis and P5 is when rods are differentiating (Young 1985a).  These spots were
hand picked and submitted for identification by MALDI-MS/MS.  We performed a
manual verification of the protein identities, which is not customarily done.  Once
identities were returned, we compared the identified proteins’ isoelectric focusing point
(pI) and the molecular weight (MW) to the spot placement on the gel. If they did not fall
within plus or minus one unit in either direction for pI and MW, they were not considered
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reliable ID’s.  This is because anything outside of this range was thought to be an
unreliable identification.  Further, we performed an internet search of Pubmed for these
proteins associated with the retina, CNS development and/or cancer.
The total number of spots picked was 239.  Of these, 170 returned reliable results
for a percentage value of 71.1.  There were 60 spots picked from E17 gels and 44 were
identified.  At P0 there were 56 proteins picked and 21 of these were reliably identified.
Of 123 protein spots picked at P5, 102 were identified.  There were 23 protein
identifications present in multiple spots, i.e. with differing MW’s, pI’s or both.  This
result suggests the possibility of post-translational modifications.  Common post-
translational modifications include phosphorylation and glycosylation.  These proteins
could be examined in the future for the presence of post-translational modifications.  For
example, the use of a phosphoprotein stain could identify proteins that have been
phosphorylated post-translationally.  These modifications may give a more in depth
picture of what these proteins roles are in rod photoreceptor cell fate.  There were many
proteins identified that had never before associated with the retina or retinal development.
Of these proteins some were associated with CNS development while others were
associated with neoplastic processes.
We discovered that there are some limitations to this approach.  It was more
difficult than anticipated to compare the protein database results to existing RNA
databases. There could be many reasons for this. For example, the presence of RNA does
not necessarily indicate the presence of the translated protein. Also, even at 71% protein
identification, which is considered successful in this method, there are obviously proteins
present but unaccounted for because they were simply not identified.  Additionally, this
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broad discovery based approach is costly and time consuming. It was perhaps an overly
ambitious endeavor.
4.2 Recommendations for further research
There are many future directions for this work.  The proteins represented by
multiple spot areas could be examined for post-translational modifications.  The most
common post-translational modification is phosphorylation (Paradela and Albar 2008).
This could be examined using a readily available phosphoprotein gel stain and imaging.
The presence of glycosylation could be studied using a glyco stain and imaging
(Temporini et al. 2008).  The proteins associated with cancer could be looked at for a role
in the cell cycle of retinal development.  Those proteins associated in the literature with
CNS development could be investigated for their role in retinal development.  Any of the
proteins could be examined as we did for mTOR, first looking at it’s distribution in
retinal tissues during development and then performing a functional study by exciting or
inhibiting the protein in retinal explants when reagents are available.  Molecules best
suited to study would be those associated with a signaling pathway.
The second approach was to examine one specific protein, mTOR, and it’s role in
rod photoreceptor fate.  The insulin-like growth factor-1 (IGF-1) was previously found to
promote rod photoreceptor differentiation (personal communications, Hecker and
Greenlee).  Since mTOR is an important cell growth and proliferation molecule
downstream of IGF-1 we hypothesized that the observed IGF-1 effect may be the result
of signaling through the mTOR signaling pathway.  We characterized mTOR
immunoreactivity (mTOR-IR) in retinal tissues during development.  We then examined
its binding partners, raptor and rictor, in retinal tissues during development.   The
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function of mTOR in retina has not been described but it has a role in cell growth and
proliferation in other tissues.  To examine its role in rod photoreceptor development we
inhibited it with rapamycin in E17 retinal tissue explants.  The embryonic age day 17 was
chosen because this is an age prior to the peak of rod photoreceptor genesis.  The
explants were cultured for 10 days.  This effect was not observed in P0 explants.
mTOR immunoreactivity was seen in the developing retina at all ages and was not
limited to one layer or cell type.  The hyperspectral results confirmed that mTOR was in
the rod photoreceptor outer segments.  The binding partners for mTOR, raptor and rictor,
were also present throughout development.
mTOR inhibition causes a decrease in rod photoreceptors. In the E17 retina,
inhibition of mTOR with 0.1uM rapamycin decreased rod photoreceptor differentiation
by 19.3% when compared to the control.  Compared to control, 1uM rapamycin
decreased rods by 16.2% and 5uM decreased rods by 28.8%. Our results suggest that
mTOR has a role in modulating rod photoreceptor differentiation. Future directions
include determining other molecules that are involved with mTOR in modulating rod
differentiation. Another experimental approach could look at what happens to these cells.
Rods are downregulated but is there another cell that is upregulated?  Is there just a delay
in rod differentiation or could they be in a suspended undifferentiated state?  Another
question that could be asked is what happens to the rod photoreceptors when mTOR is
stimulated.
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4.3 Concluding remarks
My goals for this PhD study were to examine retinal development focusing on
cell fate decisions of rod photoreceptors.  By taking a proteomics approach I achieved
part of this goal by getting a snapshot of many of the proteins present during the ages
important for rod photoreceptor development.
To summarize, I characterized protein expression in developing mouse retina at
ages important to rod photoreceptor development.  I then identified and characterized a
signaling  molecule that can modulate rod differentiation.  These are contrasting
approaches with the first being a very broad method examining all the expressed proteins
as opposed to the second approach that characterizes only one molecules’ role in rod
differentiation.  Both of these approaches served to increase our knowledge of the
mechanisms of rod photoreceptor development.
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